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ABSTRACT 
Polycyclic aromatic hydrocarbons (PAH) are omnipresent environmental pollutants composed of 
fused benzene rings and mainly produced by incomplete combustion of organic material. PAH 
exposure has been associated with increased risk of cancer and probably cardiovascular disease 
(CVD). In one way or another, everyone is exposed to PAH, but the dose and the period of 
exposure vary between individuals. Workers who remove soot from chimneys (chimney sweeps) 
are likely exposed to higher levels of PAH compared with the general population. However, 
whether the current PAH exposure among chimney sweeps leads to disease is not known.  
The overall aim of this thesis was to evaluate PAH exposure among currently working chimney 
sweeps as well as explore early biomarkers related to cardiovascular disease (CVD) and cancer. 
For this purpose, we recruited 151 chimney sweeps and 152 unexposed control individuals, all 
males from southern Sweden, from whom we collected questionnaires and biological samples. In 
one of the studies, we additionally used data and biological samples from 19 creosote-exposed 
workers, i.e. workers who impregnate wood panels with black oily material rich in PAH known 
as creosote.  
We found that PAH exposure (measured as PAH metabolites in urine) was up to 7 times higher 
among chimney sweeps compared with unexposed control workers, and the levels of PAH 
metabolites were positively associated with diastolic blood pressure. Moreover, we found higher 
serum concentrations of the classical risk markers for CVD (homocysteine and cholesterol) in 
chimney sweeps, compared with controls. Further, we found 25 putative CVD-related serum 
proteins differentially expressed between nonsmoking chimney sweeps and controls, among 
which follistatin (FS), heat shock protein beta-1 (HSP 27), and pro-interleukin-16 (IL-16) showed 
positive dose-response relationships with PAH metabolites. Pathway analysis demonstrated that 
these 25 proteins were mainly involved in inflammatory response and immune function.  
We also demonstrated hypomethylation (lower methylation) of the genes F2RL3 and AHRR, risk 
markers for lung cancer, among chimney sweeps and creosote-exposed workers, compared with 
controls. Notably, creosote-exposed workers had the highest PAH exposure and the lowest DNA 
methylation, compared with both chimney sweeps and controls, which suggests a dose-response 
relationship. In addition, we found 17 putative cancer-related serum proteins differentially 
expressed between nonsmoking chimney sweeps and controls, among which kallikrein-13 
(KLK13) showed positive dose-response relationships with the metabolites of carcinogenic PAH 
(BaP and BaA). Pathway analysis showed that most of the differentially expressed proteins were 
involved in cell movement, cell migration, and cell invasion.  
Overall, findings from this thesis indicate that (i) currently working chimney sweeps are markedly 
exposed to PAH, (ii) chimney sweeps showed molecular changes related to CVD and cancer, and 
(iii) some of these molecular changes seem to be, at least partly, induced by PAH exposure. These 
results stress that protective measures are warranted to reduce PAH exposure among chimney 
sweeps as well as other occupational groups at risk of PAH exposure. In addition, further research 
exploring mechanisms of PAH-induced CVD and cancer is encouraged in order to develop 
strategies of early detection of disease among individuals known to be exposed to PAH.   
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1 INTRODUCTION 
Work environment can play a substantial role for human health. The World Health Organization 
(WHO) has estimated that there are around 300 000 work-related mortalities per year in the 
European region (WHO 2019a). Recently, the occupational burden of disease in Europe 
constituted 1.6% of total burden of disease, and exposure to carcinogens accounted for 18% of 
this occupational burden, after injuries (40%) and noise (22%) (WHO 2019b). Exposure to toxic 
agents is common in workplaces of several professions. It was estimated that about 32 million 
workers in the European Union are occupationally exposed to toxic agents, of whom 900 000 
workers, including 18 000 in Sweden, are exposed to polycyclic aromatic hydrocarbons (PAH) 
(Kauppinen et al. 2000). Occupations such as chimney sweeping, creosote impregnation, 
aluminium production, coal tar distillation, coke production, and asphalt paving involve high 
exposure to PAH (ATSDR 2009; IARC 2010).  
Light has been shed on adverse health effects attributable to chimney sweeping as early as 1775. 
Back then, Sir Percivall Pott, an English surgeon, found overrepresentation of scrotal cancer cases 
among chimney sweeps who were highly exposed to soot, suggesting causality between exposure 
to soot and cancer (Pott 1775). Scrotal cancer as well as other types of skin malignancies were 
frequently reported among chimney sweeps later on (IARC 2012; Melicow 1975). Despite early 
efforts trying to promote safe work conditions, chimney sweeps still had work-related adverse 
health outcomes (Kipling and Waldron 1975). Recent epidemiological studies among chimney 
sweeps have demonstrated increased mortality and incidence of cancer of the lung, esophagus, 
liver, bladder, prostate, haematolymphatic organs, bowel, colon, and pleura, as well as increased 
mortality and incidence of cardiovascular disease (CVD) such as coronary heart disease, 
ischaemic heart disease, and myocardial infarction, (Evanoff et al. 1993; Gustavsson et al. 1987; 
Gustavsson et al. 1988; Gustavsson et al. 2013; Hogstedt et al. 1982; Hogstedt et al. 2013; Jansson 
et al. 2012). The main suspect driver of these health problems has been soot, which contains high 
amounts of PAH. Recently, the International Agency for Research on Cancer (IARC) has 
classified “soot, as found in occupational exposure of chimney sweeps” as carcinogenic to 
humans (Group 1) (IARC 2012).  
However, it is not known what PAH and what levels chimney sweeps are exposed to today, and 
whether this exposure leads to disease. 
 
2 BACKGROUND 
2.1 CHIMNEY SWEEPING PROFESSION 
Chimney sweeping traditionally involved removing soot (black sweeping or soot sweeping) from 
chimneys (Figure 1) and boilers using brushes, scrapers, and other equipment; however, 
additional work tasks were introduced in the recent decades. Nowadays, chimney sweeps perform 
soot sweeping tasks (in private homes and industrial facilities) and non-soot sweeping tasks such 
as inspection of fire safety systems, boilers, and furnaces, as well as cleaning ventilation channels 
in villas, houses, residential and industrial buildings. Further, cleaning exhaust ducts in restaurants 
and carrying out mandatory ventilation inspection and administrative work have increasingly 
been becoming a part of chimney sweeps’ work routine.  
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The use of personal protective equipment has improved over time. In the 18th century when Sir 
Pott reported his landmark investigation, young chimney sweeps were sent naked inside chimneys 
and therefore, the soot was lodged in the scrotal skin explaining the high incidence of cancer of 
the scrotum (Herr 2011; Kipling and Waldron 1975; Pott 1775). Such practice does not exist 
anymore in Europe. Today, chimney sweeps use gloves, masks, protective clothing, vacuum 
machines, and other auxiliary equipment during work. Yet, there is a gap between the intended 
and the actual practice of applying protective measures. There are no mandatory guidelines 
regarding the use of protective equipment during work. Chimney sweeps usually wear long-
sleeved shirts and long trousers especially in winter, but they may also wear T-shirts and shorts 
in summer, which makes them more exposed to hazardous substances while sweeping 
(Alhamdow et al. 2017a).   
 
 
 
 
 
 
 
 
 
 
 
Figure 1. A chimney sweep working in Sweden (photographer; Ayman Alhamdow, 2018). 
2.2 WORK ENVIRONMENT OF CHIMNEY SWEEPS 
Working as a chimney sweep demands a level of physical capability in order to perform different 
tasks e.g. climbing up the buildings’ roofs to clean chimneys. Such work clearly harbors high risk 
of falling accidents and other physical injuries. Even though physical injuries are of paramount 
importance, our focus in this thesis has been chimney sweeps’ exposure to PAH from soot. 
Besides soot, chimney sweeps may be exposed to asbestos used for insulation in different types 
of ducts and furnaces, dust particles, degreasing chemicals, polychlorinated dibenzo-p-dioxins 
and polychlorinated dibenzofurans (PCDDs/PCDFs), sulfur dioxide, arsenic, cadmium, and lead 
(Bagchi and Zimmerman 1980; Kapfhammer et al. 1990; Wrbitzky et al. 2001). Therefore, the 
exposure profile of chimney sweeps is complex; however, soot dominates as soot sweeping is, by 
far, the main task for most of the chimney sweeps (Alhamdow et al. 2017a). 
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2.3 SOOT: SOURCE AND COMPOSITION  
Soot is a black material resulting as a by-product from incomplete combustion of organic matter 
(e.g. wood, petroleum oil, gasoline, and coal). The composition and physical characteristics of 
soot may vary depending on the fuel used and conditions of combustion. 
In addition to PAH that are attached to carbon particles, soot may contain metals and metalloids 
(e.g. nickel, lead, cadmium, chromium, and arsenic), oxides (sulfur dioxide), combustion gases 
(carbon monoxide), and traces of other compounds (Figure 2). In general, soot produced from 
burning wood contains very low concentrations of metals, whereas soot produced from heavy 
petroleum oil contains higher metal concentrations (Fehrmann 1982; cited in IARC 1985). In the 
same study, Fehrmann found that more PAH were produced at lower combustion temperatures 
and from burning woods (compared with burning petroleum oil).   
 
 
 
 
 
 
 
 
Figure 2. Composition of soot (IARC 1985). 
2.4 POLYCYCLIC AROMATIC HYDROCARBONS (PAH) 
2.4.1 Structure, characteristics and source of exposure  
PAH are a large group of compounds consisting of two or more fused benzene rings (Fetzer 2007) 
(Figure 3). They may occur naturally (e.g. crude oil and coal) or from incomplete combustion of 
organic matter such as fossil fuel, coal, and wood (IARC 1985). PAH are usually found as a 
mixture accompanying each other, unless manufactured at the industrial level as individual pure 
chemicals (ATSDR 1995). Pure PAH are colorless, white or yellowish powders with faint 
pleasant odor. Some of PAH with low molecular weight (up to four benzene rings) can be volatile 
and spread throughout the atmosphere, however, PAH with higher molecular weight are solid and 
often adsorbed to particles in the ambient air (IARC 2010). Both forms can be precipitated by 
rainfall contaminating water sources and soil and thereafter, plants and animals (IARC 1985; 
IARC 2010). PAH can be broken down to simpler compounds by sunlight or microorganisms 
over a period of days to months (ATSDR 1995). PAH are relatively inert procarcinogens, but 
they manifest their carcinogenic potentials upon metabolic activation (Gelboin 1980). 
Soot 
Soluble organic matter Inorganic matter Particulate carbon and insoluble 
carbonaceous matter 
PAH and their 
derivatives 
Oxides, salts, metals, sulfur and 
nitrogen compounds, water and 
other absorbed liquids and gases 
Different forms of particulate 
carbon, resins and incompletely 
carbonized fuel fragments 
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Burning fuels for residential heating purposes, automobile exhaust, asphalt and coke production, 
municipal trash incineration facilities, volcanoes eruptions, wildfires and industrial activities are 
major contributors to increased ambient air burden of PAH. Other sources of PAH include 
tobacco smoking, pharmaceutical preparations that contain coal tar, and consumption of grilled, 
fried and charbroiled food (ATSDR 1995). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Chemical structure of different PAH (Forsgren 2015). 
2.4.2 PAH exposure in the general population 
The general population may be exposed to PAH from different sources and through multiple 
routes. Exposure from ambient air can be dominant, not only in highly polluted residential areas 
that are in close proximity to industrial activities, but also in areas with regular automobile traffic 
(Zmirou et al. 2000). In fact, IARC has classified several sources of PAH exposure including 
“tobacco smoking” (both active and passive), “outdoor air pollution”, “indoor emissions from 
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household combustion of coal”, and “diesel engine exhaust” as carcinogenic to humans (Group 
1) (Table 1) (IARC 2012). Several studies have evaluated non-occupational exposure to PAH in 
the general population by measuring PAH metabolites in urine. Median concentration of urinary 
1-hydroxypyrene (1-OH-PYR; a urinary metabolite of pyrene; see section 2.4.5 for further 
details) was (0.027 µg/L) for participants from Italy (Tombolini et al. 2018), (0.06 µg/L) 
Australia, (0.38 µg/L) Vietnam (Thai et al. 2015), (0.38 µg/L) China, (0.075 µg/L) Japan, (0.42 
µg/L) India, (0.065 µg/L) Malaysia, (0.10 µg/L) Korea, (0.22 µg/L) Kuwait (Guo et al. 2013), 
and (0.11 µg/L; 2009–2010) from the U.S. (CDC 2019). The digestive system can also receive 
considerable doses of PAH from consumption of smoked, broiled, fried, and grilled meat as well 
as from contaminated water, cow’s milk, human breast milk, cereals, bread, vegetables, fruits, 
and processed and pickled food items (ATSDR 1995). The U.S Environmental Protection Agency 
(EPA) has determined a “maximum contaminant level” in drinking water for different PAH 
between 0.1-0.4 ppb (0.2 ppb for Benzo[a]Pyrene (BaP)) (ATSDR 2009). However, the Swedish 
National Food Agency (Livsmedelsverket) has considered ≥0.1 ppb of BaP in water as 
“unsuitable” for drinking (Livsmedelsverket 2014). Skin is another route of exposure especially 
when using topical pharmaceutical preparations that contain coal tar for treatment of some dermal 
diseases e.g. psoriasis (ATSDR 1995; ATSDR 2002). 
2.4.3 PAH exposure in chimney sweeps 
A few studies have examined chimney sweeps’ exposure to PAH. Knecht et al. (1989) measured 
benzo[b]fluoranthene, BaP, chrysene, dibenz[a,h]anthracene, and indeno[1,2,3-cd]pyrene in the 
breathing zone of chimney sweeps during work and in soot samples from oil fuel, solid fuel, and 
a mixture of both. The PAH air concentrations were fuel-dependent as the highest concentrations 
(total PAH) were found in oil/solid fuel mixture and pure solid fuel compared with oil fuel (5.06, 
5.08, and 2.27 µg/m3, respectively). The air concentrations of BaP followed the same pattern i.e., 
0.83, 0.82, and 0.36 µg/m3 for the mixture, solid fuel, and oil fuel, respectively). When evaluating 
the soot content of PAH, the fuel mixture produced the highest amount of PAH compared with 
oil and solid fuels i.e., 691, 243, and 214 mg/kg, respectively (Knecht et al. 1989). The exposure 
to PAH was assessed in another group of chimney sweeps from Germany n=93 and Poland n=7 
(Letzel et al. 1999). The median concentration of 1-OH-PYR in the total group was 0.7 µg/L and 
ranged (<0.1–12.8 µg/L). The authors indicated that the concentrations of 1-OH-PYR were 
approximately 5 times higher among the Polish chimney sweeps; likely due to higher use of wood 
and coal in Poland compared with Germany. Further, the concentration of 1-OH-PYR was 1.03 
µg/L (median) in another German study of 27 sweeps (Göen et al. 1995) and 1.6 µg/L (mean) in 
an Italian study including 27 chimney sweeps (Pavanello et al. 2000). 
2.4.4 PAH exposure in other occupational groups 
Working in coke industry (production of coke from coal by heat in absence of oxygen) is one of 
the most studied occupations in relation to PAH exposure. Particular attention has been paid to 
occupational exposure among coke oven workers who were shown to be highly exposed to PAH 
in multiple studies. A wide spectrum of urinary concentrations of 1-OH-PYR has been reported 
in the literature e.g. mean concentrations of 1-OH-PYR ranged between 10.1–55.9 µg/L (Strunk 
et al. 2002) and 3.2–15.7 µg/L (Ovrebø et al. 1995). Rubber industry is another example of work 
environment with exposure to PAH. A study on nonsmoking rubber workers found that the mean 
concentrations of 2-naphthol in urine (a urinary metabolite of naphthalene) was increased in the 
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post-shift samples (13.9 µg/L) compared to pre-shift ones (8.0 µg/L) (Talaska et al. 2012). In the 
tar distillation industry, Price et al. (2000) reported median urinary 1-OH-PYR of 1.0 µg/L for 
the low-temperature carbonization of coal and 7.4 µg/L for the high-temperature process (Price 
et al. 2000; cited in IARC 2012). Further, workers at creosote impregnation plants (creosote-
exposed workers) are exposed to PAH from creosote oil used to preserve wooden railway ties 
(sleepers) (Elovaara et al. 1995; IARC 2010) (Figure 4). Creosote-exposed workers are 
particularly exposed through skin to PAH with low molecular weight such as naphthalene and 
phenanthrene (IARC 2010). Table 2 summarizes PAH exposure among several occupational 
groups.  
 
 
 
 
 
 
 
 
 
 
Figure 4. Source and composition of creosote (IARC 2010). 
2.4.5 Assessment of PAH exposure 
1-hydroxypyrene (1-OH-PYR), a monohydroxylated metabolite of pyrene, has widely been used 
as a biomarker (see section 2.5 for more details on biomarkers) of occupational exposure to total 
PAH due primarily to high abundance of pyrene in most PAH mixtures (Hansen et al. 2008; 
Jongeneelen 2001; Jongeneelen et al. 1988; Jongeneelen et al. 1985). The first international 
workshop on hydroxypyrene considered 1-OH-PYR as a suitable biomarker for occupational 
exposure to PAH (Levin 1995). 1-OH-PYR was also suggested as a reliable biomarker for 
monitoring environmental exposure to PAH owing to its sensitivity, specificity, and analytical 
feasibility (Bouchard and Viau 1999; Dor et al. 1999). Even though it is a metabolite of non-
carcinogenic PAH, 1-OH-PYR was suggested as a comprehensive biomarker for assessment of 
exposure to carcinogenic PAH in coke oven emissions (Yamano et al. 2014). In workplaces, such 
as creosote impregnation facilities, where high exposure to low-molecular-weight volatile PAH 
(two benzene rings) is predominant, 1-OH-PYR might not be the metabolite of choice for 
exposure assessment since it better correlates with PAH that have 3-6 benzene rings (Elovaara et 
al. 1995). Thus, assessment of both 1-OH-PYR and additional metabolite(s) is recommended 
(Elovaara et al. 1995; Heikkilä et al. 1997). 3-hydroxybenzo[a]pyrene (3-OH-BaP), a metabolite 
of the carcinogen BaP, has been suggested as a biomarker of exposure to carcinogenic PAH in 
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various workplaces (Förster et al. 2008). However, the levels of 3-OH-BaP in urine, particularly 
when analysing low occupational exposure levels, are 3 orders of magnitude lower compared 
with 1-OH-PYR and thus, the analytical method is more challenging (Barbeau et al. 2017; 
Leroyer et al. 2010). 
Recent studies have focused on analysing a wide spectrum of monohydroxylated PAH 
metabolites in order to obtain a better exposure assessment. Such metabolites include, among 
others, 1- and 2-OH-naphthalene, 2-, 3-, and 9-OH-fluorene, 1-, 2-, 3-, 4-, and 9-OH-
phenanthrene, 3-hydroxybenz[a]anthracene (3-OH-BaA), and alkylated metabolites such as 3-
methyl-1-OH-naphthalene (Fan et al. 2012; Li et al. 2012b; Li et al. 2014). Further, 
dihydroxylated PAH metabolites in urine such as 1,2-dihydroxynaphthalene were considered for 
exposure assessment (Klotz et al. 2011), however, the method is burdensome due to instability of 
the free forms of these metabolites (Zobel et al. 2017). Stability of urinary hydroxylated PAH 
metabolites varies considerably depending on storage temperature and whether the metabolite is 
in free form or conjugated (e.g. glucuronide-conjugated) (Gaudreau et al. 2016). Although free 
metabolite forms are less stable than the conjugated ones, studies showed that both types of 
metabolites can be stable for at least one year of storage at –20Cº (Gaudreau et al. 2016). In 
general, hydroxylated PAH metabolites can be used for estimation of recent PAH exposure due 
to their short half-lives (Buckley and Lioy 1992; Castano-Vinyals et al. 2004; Lutier et al. 2016). 
For assessment of long-term PAH exposure, measurement of PAH-DNA adducts in leukocytes 
or PAH-protein adducts would be the biomarker of choice since their half-lives are in order of 
months and weeks, respectively (Castano-Vinyals et al. 2004). However, we did not measure 
these long-term biomarkers in our studies owing to the fact that the levels of PAH-DNA/protein 
adducts are much lower than the OH-PAH metabolites and the analysis is more laborious and 
requires a large amount of sample. 
2.4.6 Occupational PAH exposure limits  
Several agencies and researchers have proposed exposure limits for workers exposed to PAH at 
workplace based on either biological monitoring of 1-OH-PYR and 3-OH-BaP in urine, or 
measurement of BaP in air. Here, two terms should be defined i.e. tolerable risk and accepatable 
risk. As defined by the UK Health and Safety Executive (HSE), tolerable risk “refers to a 
willingness by society as a whole to live with a risk so as to secure certain benefits in the 
confidence that the risk is one that is worth taking and that it is being properly controlled. 
However, it does not imply that the risk will be acceptable to everyone, ie that everyone would 
agree without reservation to take the risk or have it imposed on them” (HSE 2001). The acceptable 
risk is the risk that is generally accepted by the society and the regulators and widely considered 
insignificant and controlled (HSE 2001). The Health Council of the Netherlands (De 
Gezondheidsraad) has evaluated the risk of exposure to PAH using BaP as a proxy and set an 
occupational exposure limit of 550 ng/m3 for tolerable risk and 5.7 ng/m3 for acceptable risk 
(DeGezondheidsraad 2006). The German Federal Institute for Occupational Safety and Health 
(BAuA) has proposed BaP concentration of 700 ng/m3 as a tolerable risk limit (4 per 1000 excess 
mortalities from cancer), and 7 ng/m3 as an acceptable risk limit (4 per 100 000 excess mortalities) 
(BAuA 2011). Moreover, the Swedish Work Environment Agency (Arbetsmiljöverket) has set 
an occupational exposure limit for BaP at 2000 ng/m3 during an 8-hour working day, and at 
20 000 ng/m3 for a 15-min exposure period. These levels are binding and should not be exceeded 
at workplaces (Arbetsmiljöverket 2018). The UK Health and Safety Laboratory (HSL) has 
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suggested urinary 1-OH-PYR concentration of 4.0 µmol/mol creatinine (7.7 µg/g creatinine) in 
post-shift samples as a Biological Monitoring Guidance Value (BMGV) (HSL 2017). BMGV is 
not derived from health-based assessment meaning that exceeding this limit does not necessarily 
pose health risk, but rather a signal for further corrective action in occupational measures and 
conditions at workplaces. The American Conference of Governmental Industrial Hygienists 
(ACGIH) has used the limit of 200 000 ng/m3 of “benzene-soluble coal tar pitch fraction” in air 
at the workplace as a threshold limit value (TLV) for an 8-hour workday (40 hours a week). 
However, ACGIH could not set a numerical scientific value (known as Biological Exposure 
Index; BEI) of exposure to PAH due to lack of sufficient data. Nevertheless, the BEI committee 
has concluded that the occupational exposure to PAH is evident when 1-OH-PYR concentrations 
in post-shift urine samples are above 0.5 µmol/mol creatinine (1.0 µg/g creatinine) (ACGIH, 
2010; cited in Jongeneelen 2014). Again, the committee of BEI did not indicate health risk related 
to this level of 1-OH-PYR or higher. Similar to ACGIH, the American Occupational Safety and 
Health Administration (OSHA) has suggested 200 000 ng/m3 of “benzene-soluble coal tar pitch 
fraction” as permissible exposure limit (PEL), and the American National Institute for 
Occupational Safety and Health (NIOSH) has recommended 100 000 ng/m3 of airborne coal tar 
pitch as an exposure limit over a 10-hour workday (ATSDR 2009).  
To date, no risk-based occupational limit of 1-OH-PYR has been set due to lack of longitudinal 
epidemiological data on mortality of cancer in relation to 1-OH-PYR concentrations in urine. Yet, 
researchers have tried to set a guideline value for urinary 1-OH-PYR of unexposed controls and 
exposed workers at workplace. Frans J. Jongeneelen has proposed a standard guideline for 
concentrations of 1-OH-PYR in urine composed of three main levels. First, the 95th percentile of 
urinary 1-OH-PYR for non-occupationally exposed controls was chosen as a reference value 
(baseline excretions) and set at 0.46 and 1.47 µg/g creatinine for nonsmokers and smokers, 
respectively. Second, the level of no-biological-effect (the lowest reported level with no 
genotoxic effect) among occupationally exposed individuals was suggested at 2.7 µg/g creatinine. 
Third, the occupational exposure limits for workers in coke and primary aluminium industries 
were proposed at 4.4 and 9.5 µg/g creatinine, respectively (Jongeneelen 2001). Recently, 
Jongeneelen has reviewed nine studies on occupational PAH exposure and genotoxicity and 
suggested 1.0 µmol/mol creatinine (1.9 µg/g creatinine) of 1-OH-PYR in urine as a threshold or 
guideline value (Jongeneelen 2014). This guideline value corresponded to 5% probability of 
increased sister chromatid exchange in a study on Polish coke oven workers (Siwinska et al. 
2004). Overall, a health-based assessment for occupational exposure limits of 1-OH-PYR and 
other relevant PAH metabolites is warranted in future studies. 
2.4.7 Toxicokinetics of PAH  
2.4.7.1 Absorption 
PAH are hydrophobic and can be easily absorbed by diffusion through plasma membranes in the 
airways tracts, gastrointestinal tracts (GIT) and skin. Upon absorption, PAH are distributed to 
different organs and tissues, particularly the adipose tissue. Regardless of route of exposure, 
absorption of PAH with two or three rings is generally faster and easier than of those with higher 
number of aromatic rings (ATSDR 1995). In the airway tracts, exposure may occur to both 
gaseous PAH (such as naphthalene) and solid PAH (high molecular weight) adsorbed to particles, 
which results in different absorption profiles. While gaseous PAH are rapidly absorbed, particle-
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attached PAH vary in their extent and rate of absorption depending on particle size, molecular 
weight of individual PAH, reactivity, susceptibility to metabolism and desorbability rate (ATSDR 
1995). An essential fraction of particle-attached PAH is deposited in the upper airways and 
tracheobronchial tracts and thereafter cleared by the mucociliary escalators into the GIT, altering 
the route of exposure (IARC 2010; Sun et al. 1982; Withey et al. 1994). Other important 
determinants of absorption include the lipophilicity of PAH, thickness of the epithelium at which 
the absorption occurs, and local metabolism. High molecular weight PAH can easily pass the first 
membrane in the respiratory epithelium, but then are slowly transported into the next membrane 
because of the aqueous environment of the gaps between membranes. This explains the long 
retention time (several hours) of PAH when passing through the bronchial epithelium (50 µm) 
compared with few minutes through the alveolar epithelium (0.5 µm) (Gerde et al. 1991; Scott 
2001). Local metabolism (phase I and II) gives rise to more water-soluble metabolites 
accelerating their absorption through lipid membranes and preventing accumulation of 
unmetabolized PAH in the epithelial cells (Gerde et al. 1997).   
PAH may enter the GIT from oral intake, mucociliary clearance in the upper airway tracts, and 
from biliary excretion. PAH are absorbed from the GIT by either diffusion or normal absorption 
similar to nutritional lipids (IARC 2010; O'Neill et al. 1991). Absorption of PAH from the 
alimentary tracts is evident but generally slow in humans (ATSDR 1995; Buckley and Lioy 1992; 
Kang et al. 1995) and is subjected to interindividual variations (up to eight-fold difference) (Kang 
et al. 1995). It was estimated that 14-43% of the pyrene administered to nonsmoking individuals 
in food was detected in urine as 1-OH-PYR (van Maanen et al. 1994). In rats and mice, the 
absorption is rapid and varies depending on the lipophilicity of individual PAH and can be 
influenced by concurrent ingestion of oil (Modica et al. 1983; O'Neill et al. 1991). A study in rats 
showed that at least 30% of BaP dose was absorbed from the GIT (Foth et al. 1988). Another rat 
study showed that the intestinal absorption of 4- or 5-ringed PAH was facilitated by presence of 
bile (Rahman et al. 1986).  
Dermal absorption of PAH is generally rapid in humans and animals, and the rate of absorption 
varies depending of the lipophilicity of PAH and the carrying particles or vehicles (ATSDR 
1995). Stratum corneum is the outmost layer of the skin and contains several layers of dead cells 
called keratinocytes. These cells are surrounded by extracellular lipids (sterols, ceramides, and 
fatty acids) that can retain and release PAH slowly into deeper epidermic strata and then 
circulation, while less lipophilic PAH and their metabolites can travel faster across the epidermis 
(Elias and Friend 1975; Long et al. 1985; Melikian et al. 1987; Yardley and Summerly 1981). 
Animal studies showed that PAH can be locally metabolized in the epidermis forming reactive 
metabolites (Melikian et al. 1987). Occupational exposure to PAH (e.g. pyrene and BaP) through 
skin has been reported among workers in different workplaces and industries such as asphalt 
paving, chimney sweeping, creosote impregnation, petrochemical industry, and coke oven 
industry (Boogaard and Vansittert 1995; Elovaara et al. 1995; Fustinoni et al. 2010; Kammer et 
al. 2011; Sobus et al. 2009a; Van Rooij et al. 1993a; Van Rooij et al. 1993b). A study among coke 
oven workers showed that dermal exposure to pyrene accounted for around 75% total pyrene 
exposure (Van Rooij et al. 1993a). Another study on creosote-exposed workers found that the use 
of overall protectors reduced dermal exposure to pyrene by 35% (Van Rooij et al. 1993b). Animal 
studies have also indicated rapid and extensive dermal absorption of pyrene and BaP (ATSDR 
1995; Ng et al. 1992; Sanders et al. 1986; Withey et al. 1993a).  
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2.4.7.2 Distribution 
Animal studies showed that PAH are widely distributed into most of the tissues, particularly fatty 
tissues, within few hours after administration (ATSDR 1995). Radiolabeled BaP was found in the 
lungs, blood, liver, kidneys, adipose tissue, and fetus of pregnant rats after a 95-min inhalation 
exposure (Withey et al. 1993b). Likewise, inhalation exposure to radiolabeled pyrene resulted in 
distribution to fatty tissue, kidneys, liver, spleen, testes, and brain (Withey et al. 1994). Other 
inhalation studies reported rapid clearance of pyrene and BaP from airway tracts and distribution 
to GIT, liver, and kidneys (Mitchell and Tu 1979; Sun et al. 1982).  
Oral exposure to BaP in pregnant rats revealed that BaP could accumulate in the placenta and 
slowly crosses into the fetal tissues (ATSDR 1995; Neubert and Tapken 1988). Orally 
administered radiolabeled BaP in rats showed high affinity to proteins of the liver, lungs, and 
kidneys accounting for 50%, 40%, and 65% of the total radioactivity in these organs, respectively 
after 48 h of the exposure (Yamazaki et al. 1987). Another rat study showed that oral 
administration of pyrene resulted in distribution to fatty tissue followed by kidneys, liver, and 
lungs (Withey et al. 1991).  
The distribution of PAH following dermal exposure is poorly investigated. A study in rats showed 
that 1.3% of the total dermal dose of radiolabeled anthracene was found, after 6 days, in the liver 
and kidneys (Yang et al. 1986). Another study investigated the dermal uptake of pyrene showed 
that liver, kidneys, lungs, and adipose tissue received the highest levels of pyrene. This study also 
showed that about 50% the total dose was eliminated over the experiment period (6 days) (Withey 
et al. 1993a). 
2.4.7.3 Metabolism 
PAH are procarcinogens, which means they cannot induce carcinogenicity without being 
transformed into reactive metabolites (Alexandrov et al. 2010; Ramos and Moorthy 2005). Most 
of the metabolism-related mechanistic studies have used BaP as a model for PAH metabolism  
because of its well-documented carcinogenicity (ATSDR 1995; IARC 2010). Phase I metabolism 
of PAH generally involves three pathways; (i) cytochrome P450 monooxygenases (CYP P450; 
two-electron metabolism; mainly CYP1A1, CYP1A2, and CYP1B1) and epoxide hydrolase, (ii) 
CYP peroxidase (one-electron metabolism), and (iii) aldo-keto reductase, while phase II 
metabolism involves glutathione S-transferase, UDP glucuronosyltransferase, and 
sulfotransferase (IARC 2010). The products of phase I metabolism are radical cations, phenols, 
epoxides, diols, diol-epoxide, catechols, and quinones. Three members of these metabolites i.e. 
radical cations, diol-epoxides, and quinones (ortho-quinone) are capable of forming adducts with 
macromolecules (DNA, RNA, proteins, and lipids) (Arlt et al. 2012; Kafferlein et al. 2010; 
Kwack and Lee 2000; Moorthy et al. 2015). Upon phase I metabolism, enzymes of phase II 
metabolism are involved to form conjugates (sulfate, glucuronide, and glutathione) of different 
PAH metabolites (ATSDR 1995; IARC 2010; Saengtienchai et al. 2014). To note, other CYP 
P450 such as CYP2B, CYP2C, CYP2E, and CYP3A may have a limited role in PAH metabolism 
(IARC 2010; Shimada et al. 2001; Xue and Warshawsky 2005). Different pathways of PAH 
metabolism are illustrated in Figure 5.  
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Figure 5. Metabolism of Benzo[a]pyrene; a model for PAH metabolism, depicting different metabolic 
pathways and reactive metabolites based on the literature (ATSDR 1995; ATSDR 2002; ATSDR 2009; 
Burczynski et al. 1999; Cavalieri and Rogan 1985; Cavalieri and Rogan 1992; Cavalieri et al. 1988; 
Devanesan et al. 1992; Hall and Grover 1988; Hrycay and Bandiera 2012; IARC 1985; IARC 2010; 
Kondraganti et al. 2003; Moorthy et al. 2015; Moorthy et al. 2002; Penning et al. 1999; Smithgall et al. 1988). 
Chemical structures have been created using an online tool (http://www.chemspider.com). PHS; 
prostaglandin H synthase. DHDH; dihydrodiol dehydrogenase. AKR; Aldo-keto reductase. GST; Glutathione 
S-transferase. SULT; Sulfotransferase. UGT; UDP glucuronosyltransferase. EH; Epoxide hydrolase. NQO; 
NADPH quinone oxidoreductase. 
2.4.7.4 Excretion 
Upon metabolism, water-soluble PAH metabolites are excreted as free forms or conjugates 
(sulfate, glucuronide, and glutathione) in the urine and faeces (IARC 2010; van Schooten et al. 
1997; Viau et al. 1999); however, unmetabolized PAH can also be excreted; e.g. medians of 
urinary phenanthrene and pyrene were 0.7 and 0.02 µg/L in coke oven workers (Campo et al. 
2010; van Schooten et al. 1997). The half-life of 1-OH-PYR when excreted in urine varied 
between studies. It was estimated to be 18 h as assessed in workers of coke ovens and graphite 
electrode industry (Buchet et al. 1992). A study on a creosote worker concluded that urinary 1-
OH-PYR is excreted in a biphasic pattern with half-life of 1–2 days for the rapid phase and up to 
16 days for the late phase (Jongeneelen et al. 1988). The same authors conducted a study on coke 
oven workers and found that the half-life of urinary 1-OH-PYR ranged from 6 to 35 h 
(Jongeneelen et al. 1990). Another study reported a half-life of 4–27 h for 1-OH-PYR among 
workers exposed to PAH (Boogaard and van Sittert 1994). A study among electrometallurgy 
workers showed that the half-life for 1-OH-PYR and 3-OH-BaP ranged between 12–18 h and 5–
49 h, respectively. The shorter half-life of 1-OH-PYR in comparison with 3-OH-BaP suggests 
post-shift urine sampling as a preferred method for analysing 1-OH-PYR, but not 3-OH-BaP 
(Lutier et al. 2016). It was suggested that, for assessment of BaP exposure, pre-shift end-of-the-
workweek sampling is advantageous for work environments where the exposure is highly 
variable, while post-shift end-of-the-workweek sampling is preferred for work environments with 
invariable exposure (Barbeau et al. 2015; Barbeau et al. 2014). Controlled feeding studies in 
human volunteers showed that urinary concentrations of 1-OH-PYR were still higher than 
baseline levels after 24–72 h after exposure and inter-individual variations in 1-OH-PYR 
concentrations were up to 8 times (Kang et al. 1995). Other studies reported different but 
comparable figures for the half-life of 1-OH-PYR ranging between 4–29 h (range of medians or 
means reported in multiple studies) (Figure 6) (Boogaard and Vansittert 1994; Brzeznicki et al. 
1997; Buchet et al. 1992; Buckley and Lioy 1992; Chien and Yeh 2010; Huang et al. 2007; 
Jongeneelen et al. 1990; Lafontaine et al. 2000; Li et al. 2012b; Li et al. 2016; Lutier et al. 2016; 
Sobus et al. 2009b; St Helen et al. 2012; Viau et al. 1995; Viau and Vyskocil 1995). Overall, the 
hydroxylated urinary PAH metabolites are short-lived and can reflect recent PAH exposure.  
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Figure 6. Half-life of 1-hydroxypyrene (1-OH-PYR) reported in human studies. 
2.4.8 PAH exposure and adverse health outcomes 
Adverse health end-points, particularly cancer and CVD, were investigated in relation to exposure 
to PAH among workers in several occupations including chimney sweeping.  
2.4.8.1 Cancer 
In Sweden, the various population registries had enabled researchers to evaluate health risks in 
relationship with occupations. A large cohort of Swedish chimney sweeps (n=6320) was followed 
up from 1958 to 2006 linking nationwide registry data on cancer and cause of death with 
occupation as a chimney sweep. The study found increased incidence of cancer from the lung, 
liver, esophagus, colon, bladder, hematopoietic system, pleura, and from unspecified tissues. In 
addition, the authors indicated a dose-response relationship between years of employment and 
incidence of total cancer and bladder cancer (Hogstedt et al. 2013). A further study of the Swedish 
chimney sweeps (n=6374) with a follow-up period 1952-2006 showed that mortality among 
chimney sweeps was increased for cancers of the bowel, esophagus, liver, and lung, as well as 
for liver cirrhosis, non-malignant airway diseases, alcoholism, suicide and other causes (Jansson 
et al. 2012). Moreover, increased risks among chimney sweeps were found, in various studies, 
for cancers of the prostate, haematolymphatic system, lung, and esophagus, as well as for 
pulmonary disease, and death from accidents (Evanoff et al. 1993; Gustavsson et al. 1987; 
Gustavsson et al. 1988; Hogstedt et al. 1982).  
Not only chimney sweeps, but also other PAH-exposed occupational groups experience work-
related adverse health effects. Several lines of evidence have linked increased risk of cancer with 
working in coal-gasification (Berger and Manz 1992; Doll et al. 1972; Martin et al. 2000), coal-
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tar distillation (Henry 1947; Letzel and Drexler 1998; Maclaren and Hurley 1987; Swaen and 
Slangen 1997), coal-tar pitch (Hammond et al. 1976; Kennaway and Kennaway 1947; Partanen 
and Boffetta 1994; Swaen and Slangen 1997), coke production (Costantino et al. 1995; Swaen et 
al. 1991), aluminium production (Gibbs et al. 2007; Romundstad et al. 2000; Spinelli et al. 2006), 
and rubber manufacturing (Alder et al. 2006; Kogevinas et al. 1998; Stewart et al. 1999). These 
work environments, including chimney sweeping, were classified as carcinogenic to humans 
(Group 1) by IARC (Table 1) (IARC 2012). Researchers in collaboration with IARC have 
established 10 characteristics for human carcinogens, of which all chemicals in Group 1 
(carcinogenic to humans; IARC) manifest at least one (Smith et al. 2016). These characteristics 
of carcinogens include (i) electrophilicity, (ii) genotoxicity, (iii) epigenetic toxicity, and the ability 
to cause (iv) impairment in DNA repair system, (v) oxidative stress, (vi) inflammation, (vii) 
immune dysfunction, (viii) immortalization, (ix) cell proliferation dysfunction, and (x) 
modulation of endogenous ligands/receptors (Smith et al. 2016). While PAH are inert, their 
electrophilic metabolites (such as epoxides and quinones) can manifest some of the above-
mentioned characteristics such as forming adducts with DNA (genotoxicity) and giving rise to 
oxidative stress (Moorthy et al. 2015; Palackal et al. 2002; Smith et al. 2016). Given that, 
exploring early markers of PAH-induced carcinogenicity would provide important opportunities 
for promoting occupational health.  
2.4.8.2 Cardiovascular disease (CVD) 
Cardiovascular health outcomes have been less studied in relation to PAH exposure compared to 
cancer. Epidemiological studies among chimney sweeps have reported increased incidence and 
mortality of CVD such as coronary heart disease, ischaemic heart disease, and myocardial 
infarction (Burstyn et al. 2005; Evanoff et al. 1993; Gustavsson et al. 2013; Hansen 1983; Jansson 
et al. 2012; Letzel et al. 1992). Further, a number of studies have investigated markers of CVD in 
association with PAH exposure in the general population. In a study using the National Health 
and Nutrition Examination Survey (NHANES 2003-2004), the PAH metabolites 2-
hydroxyphenanthrene and 9-hydroxyfluorene were positively associated with the marker of 
acute-phase response to inflammation i.e. C-reactive protein (CRP), suggesting that PAH can 
induce inflammation and thus contribute to development of atherosclerosis (Everett et al. 2010). 
Other studies (NHANES 2001-2004) showed that 2-hydroxyphenanthrene was associated with 
CVD (self-reported), but no associations were found between hydroxylated metabolites of the 
PAH (naphthalene, fluorene, phenanthrene, and pyrene) and the CVD markers homocysteine (a 
key player in one-carbon metabolism), fibrinogen (a main component of the coagulation cascade), 
and white blood cell count (Clark et al. 2012; Xu et al. 2010). Recent results from studies on 
NHANES 2001-2008 and NHANES 2003-2008 showed positive associations between PAH 
metabolites (2-naphthalene and 2-phenanthrene) and hypertension (Ranjbar et al. 2015), as well 
as between PAH metabolites (2-hydroxyphenanthrene and 4-hydroxyphenanthrene) and the CVD 
markers CRP and gamma glutamyltransferase (participates in glutathione regulation) (Farzan et 
al. 2016). Similarly, PAH metabolites were associated with CRP levels and white blood cell count 
in participants from NHANES 2001-2002, 2003-2004, and 2005-2006 (Alshaarawy et al. 2013). 
Yang et al. (2016) measured 10 hydroxylated PAH metabolites (OH-PAH) in urine, plasma 
proteins, and heart rate variability in a group of coke oven workers (n=489). The authors found 
that OH-PAH were positively associated with macrophage stimulating protein, activated 
leukocyte cell adhesion molecule, and CRP, but inversely associated with heart rate variability 
  
15 
 
(Yang et al. 2016). Correspondingly, other studies in coke oven workers, boilermakers and the 
general population showed inverse associations between PAH exposure and heart rate variability 
(Feng et al. 2014; Lee et al. 2011; Li et al. 2012a). Taken together, further studies elucidating the 
potential mechanisms of PAH-induced CVD as well as exploring new CVD markers in relation 
to PAH exposure are needed.   
2.4.8.3 Other diseases 
Lung cancer has been the most studied pulmonary disease among PAH-exposed workers, while 
non-carcinogenic airway disease and symptoms have received less attention. Epidemiological 
studies among chimney sweeps have found increased mortality from nonmalignant airway 
diseases (Jansson et al. 2012) as well as higher risk for asthma, cough with phlegm, dyspnea, and 
eye symptoms (Alhamdow et al. 2017a; Hansen 1990; Li et al. 2008). A study among workers in 
rubber industry demonstrated increased risk for dry throat, hoarseness, and dry cough (Jönsson et 
al. 2007). A further study showed low measurement of ventilatory capacity and increased 
prevalence of acute and chronic respiratory diseases (cough, dry throat, tightness of the chest, 
nasal dryness and nasal bleeding) in rubber workers (Zuskin et al. 1996). Findings from a follow-
up study demonstrated that coke oven workers had lung function impairment associated with 
PAH metabolite concentrations (Wang et al. 2016). In line with these studies, the Agency for 
Toxic Substances and Disease Registry (ATSDR) has linked cough and chronic bronchitis to 
chronic occupational exposure to PAH (ATSDR 2009). PAH may also affect fertility and 
embryogenesis, however, these effects are out of the scope of this thesis (Choi et al. 2010). 
2.4.9 Mechanisms of toxicity 
BaP is a human carcinogen and has extensively been investigated in mechanistic studies in 
animals. Two main pathways have been shown to be involved in PAH-induced carcinogenicity; 
PAH-DNA adduct formation, particularly adducts of diolepoxides, radical cations, and o-
quinones, and production of reactive oxygen species (ROS) (Cavalieri and Rogan 1995; 
Henderson et al. 1989; IARC 2012; Kwack and Lee 2000).  
The BaP metabolites diolepoxides and o-quinones are potent reactive metabolites that can form 
adducts with DNA and other macromolecules (RNA, protein, and lipids) (Balu et al. 2006; 
Cavalieri et al. 2005; Chakravarti et al. 2008; Henderson et al. 1989; Meehan et al. 1977; Moorthy 
et al. 2015; Smithgall et al. 1988; Xue and Warshawsky 2005) (Figure 5). In response, the cell 
can repair depurinating PAH-DNA adducts by base excision repair and stable adducts by 
nucleotide excision repair (Braithwaite et al. 1998; Wei et al. 1995). However, once these repair 
systems fail, tumorigenic/non-tumorigenic mutations can be introduced during cell division 
(Chakravarti et al. 1995; Nelson et al. 1992; Tang et al. 2000; Zhao et al. 2006). Further, one-
electron oxidation can be catalyzed by CYP P450 or prostaglandin H synthase giving rise to short-
lived, highly reactive radical cations which can form unstable DNA adducts and cause mutations 
(Banasiewicz et al. 2004; Cavalieri and Rogan 1985; Cavalieri and Rogan 1992; Hrycay and 
Bandiera 2015a). On the other hand, ROS are produced from redox cycling of quinones/catechols, 
and quinones/hydroquinones during PAH metabolism (IARC 2010; IARC 2012; Penning et al. 
1999). ROS are very reactive and can induce carcinogenesis by causing oxidative DNA damage 
and cellular lesions in proteins, carbohydrates and lipids (Henderson et al. 1989; Hrycay and 
Bandiera 2015b; Kwack and Lee 2000).  
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BaP has been shown to induce atherosclerosis in pigeons, cockerels, and mice (Majesky et al. 
1983; Ramos and Moorthy 2005). Moreover, PAH-DNA adducts have been present in human 
vessels with atherosclerosis, which suggests a role of genotoxic effect in formation of 
atherosclerotic lesions (Binkova et al. 2001; Ramos and Moorthy 2005). However, intra-nasally 
administered BaP in rats exhibited neither increased oxidative stress nor adverse effects on the 
cardiovascular tissue, but showed altered circadian rhythm of blood pressure caused by local 
inflammation in the lungs (Gentner and Weber 2011). Summary of potential biological adverse 
effects caused by PAH exposure is provided in Figure 7. 
2.5 BIOMARKERS OF DISEASE 
The term biomarker (biological marker) encompasses a wide variety of measurable biological 
characteristics and can be defined as “a characteristic that is objectively measured and evaluated 
as an indicator of normal biological processes, pathogenic processes or pharmacological 
responses to a therapeutic intervention” (Naylor 2003). Accordingly, biomarkers can be 
biological molecules (e.g. proteins and lipids), cellular features (white blood cell count), or 
genetic/epigenetic characteristics (copy number of a specific DNA sequence and DNA 
methylation) (Dietze and Patzak 2016; Hussein et al. 2018; Liu et al. 2017). Further, biomarkers 
may also be classified as biomarkers of exposure (such as urinary 1-OH-PYR; a biomarker for 
PAH exposure) or biomarkers of disease, which may reflect disease presence (e.g. high levels of 
glucose in blood is a biomarker of diabetes mellitus) or serve as early signals for future disease 
development (Dietze and Patzak 2016; Mayeux 2004).  
In addition to the classical biomarkers related to CVD (e.g. homocysteine and lipids) (Dhingra 
and Vasan 2017; Eikelboom et al. 1999) and cancer (e.g. prostate specific antigen; PSA) (Henry 
and Hayes 2012), newly emerging biomarkers, in association with environmental and 
occupational exposures, have been evaluated in a vast array of epidemiological studies. Telomere 
length (TL; copy number of the telomeric sequence AGGGTT) and mitochondrial DNA copy 
number (mtDNAcn; copy number of the circular double-stranded DNA in the mitochondria) have 
been investigated in relation to environmental exposures such as methylmercury (Xu et al. 2019; 
Yeates et al. 2017), arsenic (Ameer et al. 2016), and air pollution (Hou et al. 2012), as well as 
occupational exposures such as PAH (Pavanello et al. 2013; Pavanello et al. 2010; Xu et al. 2018), 
and benzene (Bassig et al. 2014; Carugno et al. 2012). Moreover, TL and mtDNAcn have been 
widely evaluated in relation to cancer and CVD (Ashar et al. 2017; Haycock et al. 2017; Hu et al. 
2016; Mi et al. 2015; Wentzensen et al. 2011; Yue et al. 2018). Further, epigenetic biomarkers, 
particularly DNA methylation, have been demonstrated to be associated with exposure to various 
toxicants (Leenen et al. 2016; Martin and Fry 2018; Meehan et al. 2018) and adverse health 
outcomes such as cancer and CVD (Kim et al. 2010; Koch et al. 2018; Kulis and Esteller 2010; 
Zhong et al. 2016). Other emerging biomarkers include, but not limited to, microRNAs, long non-
coding RNAs, and various proteomic molecules. Taken together, these biomarkers can be 
promising tools for early detection of diseases in connection with environmental and occupational 
exposures.   
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2.6 RECAPITULATION 
Exposure to PAH constitutes a major health concern for the general public and even, to a larger 
extent, for workers in many work environments. PAH are omnipresent pollutants to which 
humans are exposed through inhalation, oral intake, and dermal absorption. Humans are often 
exposed to a mixture of PAH, which adds an extra layer of complexity when trying to identify 
the toxic contribution of each PAH. In vitro and in vivo toxicological studies have shown 
tumorigenic effects of a number of individual PAH, of which BaP is the most studied carcinogen. 
Registry-based epidemiological studies on chimney sweeps have found increased incidence and 
mortality of not only cancer but also CVD. However, data linking individual exposure to PAH 
with these diseases or early disease-related markers are scarce. This prompts the need for studies 
evaluating today’s PAH exposure among chimney sweeps as well as investigating early 
biomarkers linked to cancer and CVD. This project is trying to produce a unique piece of 
knowledge to advance the field of occupational research.    
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Table 1. Classification of several PAH and occupational exposures according to IARC. 
http://monographs.iarc.fr/ENG/Classification/latest_classif.php [Accessed; 04 Jan 2019]. 
PAH (exposure) 
IARC classification 
group* 
Year of evaluation 
Benzo[a]pyrene 1 2012 
Dibenzo[a,l]pyrene 2A 2010 
Cyclopenta[c,d]pyrene 2A 2010 
Dibenz[a,h]anthracene 2A 2010 
Benz[a]anthracene 2B 2010 
Benzo[c]phenanthrene 2B 2010 
Naphthalene 2B 2002 
Dibenzo[a,i]pyrene 2B 2010 
Dibenzo[a,h]pyrene 2B 2010 
Benzo[b]fluoranthene 2B 2010 
Benzo[a]fluoranthene 3 2010 
Dibenzo[a,e]pyrene 3 2010 
Pyrene 3 2010 
Phenanthrene 3 2010 
Anthracene 3 2010 
Soot (as found in occupational exposure 
of chimney sweeps) 
1 2012 
Coal gasification 1 2012 
Coal-tar distillation 1 2012 
Coal-tar pitch 1 2012 
Coke production 1 2012 
Diesel engine exhaust 1 2013 
Rubber manufacturing industry 1 2012 
Aluminium production 1 2012 
Indoor emissions from household 
combustion of coal 
1 2012 
Outdoor air pollution 1 2016 
*Group 1=(carcinogenic to humans); Group 2A=(probably carcinogenic to humans); Group 2B=(possibly 
carcinogenic to humans); Group 3=(Not classifiable as to its carcinogenicity to humans) 
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Table 2. Concentration of 1-OH-PYR; a biomarker of total PAH exposure, in post-shift urine 
samples from workers in different occupations. 
Occupational 
group 
Workers’ 
country 
n Measure 
Concentration 
(µg/g creatinine)* 
Reference 
Chimney sweeps Sweden 148 median 0.39 (Alhamdow et al. 2017b) 
Chimney sweeps 
Germany/ 
Poland 
100 median 0.5 (Letzel et al. 1999) 
Chimney sweeps Italy 27 mean 1.1 (Pavanello et al. 2000) 
Creosote-exposed 
workers 
Netherlands 10 mean 4.5 (Van Rooij et al. 1993b) 
Creosote-exposed 
workers 
Finland 6 mean 123.5 (Elovaara et al. 1995) 
Aluminium industry 
(potroom workers) 
Surinam 8 mean 34.7 (Ny et al. 1993) 
Aluminium industry 
(potroom workers) 
Netherlands 6 mean 13 (Van schooten et al. 1995) 
Aluminium industry 
(potroom workers) 
Sweden 96 mean 8.3 (Carstensen et al. 1999) 
Coke oven workers Germany 87 mean 7.1 (Förster et al. 2008) 
Coke oven workers Poland 24 median 4.4 (Mielżyńska et al. 1997) 
Coke oven workers Belgium 33 mean 1.4 (Van Hummelen et al. 1993) 
Coke oven workers Belgium 54 mean 2.9 (Ferreira et al. 1994) 
Coke oven workers Italy 95 mean 2.5 (Clonfero et al. 1995) 
Coke oven workers Poland 55 median 10.5 (Campo et al. 2010) 
Coke oven workers Poland 50 median 17.4 (Siwińska et al. 2004) 
Coke oven workers Poland 49 mean 6 (Pavanello et al. 2008) 
Workers in graphite 
electrode production 
Belgium 15 mean 12 (Van Hummelen et al. 1993) 
Workers in graphite 
electrode production 
Belgium 92 mean 6.2 (Ferreira et al. 1994) 
Workers in graphite 
electrode production 
Germany 26 mean 4.8 (Förster et al. 2008) 
Workers in graphite 
electrode production 
Germany 67 mean 8.7 (Angerer et al. 1997) 
*Different studies reported concentrations of 1-hydroxypyrene (1-OH-PYR) in different units. The reported 
values in this table (µg/g creatinine) were calculated based on the conversion factor reported in IARC 2010 as 
follows (1 µmol/mol creatinine = 1.93 µg/g creatinine = 2.84 µg/L) 
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3 AIMS 
The overall aim of this thesis was to study chimney sweeps’ exposure to PAH, elucidate the 
associations between working as a chimney sweep and early biomarkers related to development 
of CVD and cancer, and evaluate dose-response relationships with PAH exposure. The specific 
aims of the thesis were as follows:  
 To elucidate whether currently working chimney sweeps are exposed to PAH and also, to 
elucidate the associations between chimney sweeping and concentrations of PAH 
metabolites in urine with classical risk markers for development of CVD. 
 
 To explore putative CVD-related serum proteins in relation to chimney sweeping and 
concentrations of PAH metabolites in urine.   
 
 To elucidate the associations between chimney sweeping and concentrations of PAH 
metabolites in urine with DNA methylation, telomere length, and mitochondrial DNA 
copy number; markers related to DNA damage and cancer development. 
 
  To explore putative cancer-related serum proteins in relation to both chimney sweeping 
and concentrations of PAH metabolites in urine.   
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4 MATERIALS AND METHODS 
4.1 STUDY DESIGN  
The study design for all papers included in this thesis was cross-sectional.  
4.2 PARTICIPANTS 
We recruited 151 chimney sweeps (also called chimneysweepers or chimney sweepers) and 152 
unexposed control individuals from southern Sweden (counties of Skåne, Öland, Blekinge, 
Halland, Småland, and Västergötland). These two groups of workers (or a subset of them) were 
included in all four studies. A third group of 19 creosote-exposed workers from Örebro County 
was included in study III (Figure 8).  
All participants were males 19-66 years of age and all gave informed consent. We included only 
male participants because the majority of currently working chimney sweeps in Sweden are men.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8. The geographical areas in Sweden from which the study participants were recruited (adapted from 
© Scribble Maps). 
4.2.1 Chimney sweeps 
Chimney sweeps usually perform multiple daily tasks i.e. soot sweeping in private homes, soot 
sweeping in industrial facilities, inspection of fire-safety systems, cleaning ventilation channels, 
mandatory inspection of ventilation channels, cleaning exhaust-ducts in restaurants, and 
administrative work. They start their work shift in the morning driving their cars to multiple 
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clients throughout the day. After the work shift is over, they return to their company to shower 
and report their activities.  
We recruited chimney sweeps between 2013 and 2015 in co-ordination with chimney sweeps’ 
trade union (Kommunal) and the employer organization of chimney sweeps (Sveriges 
Skorstensfejaremästares Riksförbund; SSR). We started by contacting the managers of chimney 
sweeping companies to ask for participation. The managers were instructed to invite their 
employees for participation. In total, we contacted 39 chimney sweeping companies of which, 34 
were positive for participation. Due to the nature of the recruitment process, it was not possible 
to calculate the response rate for individuals. Instead, we calculated the response rate for 
companies, which was 87%. Out of the 34 companies, 4 were far-off located and one had only 
female chimney sweeps, therefore, these 5 companies were excluded (final number of companies 
n=29). We sent, via regular mail, a rationale for the study, an informed consent form, and a 
questionnaire to all chimney sweeps who had agreed to participate. We also booked a visit at the 
company facility to collect the questionnaires, measure blood pressure, weight, and height, and 
sample blood and urine. The visits were on Wednesdays or Thursdays after chimney sweeps had 
finished their work shift.  
4.2.2 Unexposed controls 
The controls were workers that had no known occupational exposure to PAH. During 2010–11, 
we contacted 12 companies/municipalities, of which 7 (6 companies and 1 municipality) agreed 
to participate, resulting in 58% company response rate. These companies were running 
warehouses or food storage facilities. We further recruited 25 currently smoking controls in 2015 
from 3 companies and 4 municipalities to match the smoking status of chimney sweeps. To note, 
it was difficult to find smoking controls currently working in a PAH-free working environment. 
The scarcity of the smoking controls had made us contact a large number of companies, several 
of which did not have smoking employees. For this reason, we could not calculate the company 
response rate. Similar to chimney sweeps, the controls filled in a questionnaire, donated blood 
and urine samples and got their weight and height measured.  
4.2.3 Creosote-exposed workers 
We recruited workers from a factory where railway switches are produced. During the production 
process, the switches are connected to wooden ties impregnated with creosote oil, which provides 
protection against humidity. The workers are exposed to creosote from handling impregnated ties, 
dripping creosote oil, and disassembling and transporting the final products i.e. railway switches. 
The workers are exposed to PAH from the creosote oil. All workers were recruited from one 
company located in Örebro County with 100% participation rate. We collected questionnaires, 
blood and urine samples from the participants.  
4.3 QUESTIONNAIRE 
The questionnaire for all study groups included questions about age, personal history of disease, 
family history of disease, airway symptoms, level of education, prescribed medication, non-
prescribed medication, tobacco smoking habit, use of snus, exposure to passive smoking, intake 
of fish, vegetables, and fruits, physical activity, exposure to dust, diesel exhaust, welding fumes 
or soldering smoke from hobbies, current residency, and employment history. The questionnaire 
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of chimney sweeps and creosote-exposed workers further explored occupational history, details 
about work environment and work conditions. For example, the extent to which chimney sweeps 
were involved in different work tasks (such as soot sweeping in private homes and soot sweeping 
in industrial facilities) was investigated for the periods 1963–72, 1973–82, 1983–92, 1993–2002, 
2003–12, and for the past 12 months. The use of protective equipment (e.g. gloves, masks, and 
overall suits) was also explored among chimney sweeps throughout different periods.  
4.4 BIOLOGICAL SAMPLES 
We collected EDTA venous blood and urine samples from chimney sweeps, controls, and 
creosote-exposed workers. From chimney sweeps and controls, we further collected serum 
samples obtained by allowing blood coagulation in SST tubes for 10 min at room temperature 
and then centrifuging at 1800 ×g for 15 min. Blood and urine samples were stored at –20°C, while 
serum samples at –80°C. 
4.5 EXPOSURE ASSESSMENT 
We analysed the monohydroxylated metabolites of the PAH pyrene, BaP, phenanthrene and 
benz[a]anthracene (BaA). Pyrene (four benzene rings) and phenanthrene (three rings) are 
classified as “not classifiable as to its carcinogenicity to humans” (Group 3) by IARC (IARC 
2010). BaP (five rings) and BaA (four rings) are classified as “carcinogenic to humans” (Group 
1) and “possibly carcinogenic to humans” (Group 2B), respectively (IARC 2010). We used liquid 
chromatography coupled to tandem mass spectrometry (LC-MS/MS) for analysis. There could 
be several isomers for each monohydroxylated metabolite that were quantified against one pure 
standard of a specific monohydroxylated PAH metabolite. For instance, the peak for 
monohydroxylated metabolites of BaP included several isomers, but the quantification was 
carried out using a pure standard of 3-OH-BaP. Therefore, we measured 1-OH-PYR, 2-OH-PH, 
3-OH-BaP, and 3-OH-BaA as proxy for exposure to pyrene, phenanthrene, BaP, and BaA, 
respectively. In short, the urine samples were treated with ß-glucuronidase in presence of 
ammonium acetate buffer. Vitamin C (for stabilization purposes) and internal standards were 
added. The samples were then injected onto an LC-MS/MS system. All samples were run in 
duplicates. Urinary creatinine and urine specific gravity were measured to correct for urine 
dilution. More details were provided in Study I (Alhamdow et al. 2017b). The exposure data 
were used in all four studies.  
4.6 MARKERS RELATED TO CVD 
4.6.1 Blood pressure 
High blood pressure is a known risk factor for CVD (Chobanian et al. 2003). We measured blood 
pressure (both systolic and diastolic) for chimney sweeps, using a mercury sphygmomanometer 
in the upright (sitting) position, during the company visit. These data were used in Study I.  
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4.6.2 Classical serum markers for CVD risk 
4.6.2.1 Homocysteine, C-reactive protein (CRP), gamma-glutamyltransferase (GGT)  
Higher levels of these markers (risk markers) have been associated with CVD (Ganguly and Alam 
2015; Ridker et al. 2002; Ruttmann et al. 2005). Serum aliquots from chimney sweeps and 
controls were used for analyses, which were carried out using standard methods at the Department 
of Clinical Chemistry, Lund University Hospital. Details of analyses were described in Study I. 
4.6.2.2 Serum lipids 
Total cholesterol, low-density lipoprotein (LDL), high-density lipoprotein (HDL), and 
triglycerides (TG) were measured in serum for chimney sweeps and controls by the same 
laboratory at the Department of Clinical Chemistry (Lund University Hospital). More details were 
described in Study I. 
4.6.3 Exploratory serum markers for CVD risk  
Among current nonsmoking chimney sweeps and controls, we measured 92 different putative 
CVD-related proteins in serum. The analysis was performed by Olink Proteomics (CVD II panel; 
Olink, Uppsala, Sweden) based on the proximity extension assay (PEA). Aliquots of serum 
samples (40 μL) were randomized in 96-well plates and shipped on dry ice to the company. A 
pooled serum sample was collected and shipped along with the samples in order to be used for 
calculations of coefficient of variation (intra- and inter-plate). In this analysis, each protein is 
targeted by a unique pair of antibodies labelled with complementary DNA sequences (PEA 
probes). These probes can hybridize upon successful protein targeting and thereafter produce a 
short piece of double-stranded DNA specific for the protein. The resulted DNA sequence is then 
amplified by real-time PCR (qPCR) and quantified by microfluidic chip (96.96 Dynamic Array 
IFC, Fluidigm Biomark). For more details, please refer to Study II and Olink’s website 
(olink.com). 
4.7 MARKERS RELATED TO CANCER 
4.7.1 Telomere length (TL) and mitochondrial DNA copy number (mtDNAcn) 
We measured relative TL and mtDNAcn in DNA extracted from whole blood samples of chimney 
sweeps, controls, and creosote-exposed workers based on a previously described method 
(Cawthon 2002). The method was based on qPCR where the copy number of telomere repeats 
(T) and the copy number of the single copy gene hemoglobin beta (HBB) (S) were calculated, 
thereafter, the relative TL was calculated as T/S. For mtDNAcn, a similar method was employed 
where the absolute mtDNAcn (M) as well as the copy number of the single copy gene (HBB) (S) 
were obtained and thereafter, the relative mtDNAcn was calculated as M/S. All samples, 
including negative controls, were run in triplicates and 10% of randomly selected samples were 
rerun to ensure analysis quality. For more details, please refer to Study III (Alhamdow et al. 
2018).  
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4.7.2 DNA methylation of the genes F2RL3 and AHRR 
F2R like thrombin or trypsin receptor 3 (F2RL3) and Aryl-Hydrocarbon Receptor Repressor 
(AHRR) are protein-coding genes consisting of 2 and 11 exons, respectively. Hypomethylation 
(low methylation) of two CpG sites (cytosine-phosphate-guanine) in these genes i.e. cg03636183 
(F2RL3; based on Illumina beadchips 450K; Illumina Inc., CA, US)  and cg05575921 (AHRR) 
were, in several studies, shown to be associated with smoking as well as lung cancer (Gao et al. 
2015; Zhang et al. 2016b). Assays for the genomic regions spanning cg03636183 and 
cg05575921 were developed based on previously published literature (Hossain et al. 2015; Wu 
et al. 2014). Additional CpG sites that were in close proximity to cg03636183 and 
cg05575921 were also considered in the analysis (Figure 9). 
We used the pyrosequencing technique to perform DNA methylation analysis for DNA extracted 
from whole blood samples of chimney sweeps, controls, and creosote-exposed workers. Briefly, 
DNA samples were treated with bisulfite, converting unmethylated cytosine (C) to uracil and 
subsequently to thymine (T), but keeping methylated C unchanged. The genomic sequence of 
interest was then amplified by PCR and thereafter, specific amplification was examined on 
agarose gel. The pyrosequencing was then carried out following a standard protocol using 
PyroMark Q96 ID platform (Qiagen). Negative and positive controls were included and 10% of 
the samples were randomly selected and rerun for quality control purposes. For more details, 
please refer to Study III. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9. (a) Location of CpG1 and cg03636183 (F2RL3 gene; chromosome 19). (b) Location of CpG1, 
CpG2, and cg05575921 (AHRR gene; chromosome 5).  
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4.7.3 Exploratory serum markers for cancer risk  
We analysed a panel of 92 putative cancer-related proteins (Oncology panel II; Olink) in serum 
using the same approach i.e. PEA provided by Olink proteomics for the same current nonsmoking 
chimney sweeps and controls involved in Study II. The same aliquots of serum (i.e. 40 μL), used 
for analysis of CVD-related proteins, were used for this analysis. For more details, please refer to 
Study IV (Alhamdow et al. 2019).  
4.8 STATISTICAL ANALYSIS 
All statistical analyses were carried out using the statistical software SPSS (IBM SPSS Statistics, 
NY, USA) and R (version 3.5.1; R core team, 2018). 
In all four studies, median value, a measure for central tendency, was calculated for continuous 
variables such as age and body mass index (BMI), while frequency was considered for categorical 
variables (smoking and use of snus). Spearman’s correlations were used to examine crude 
correlations between continuous variables. Crude differences between study groups were 
evaluated by Kruskal–Wallis test or Mann-Whitney U test for continuous variables and Fisher’s 
exact test for categorical variables. Linear regression analysis was used to investigate associations 
between study groups (binary variable) and PAH metabolites in urine (continuous variables), as 
well as between study groups and outcome markers (continuous variables) adjusting for 
confounders and covariates. Similar linear regression models were adopted to evaluate 
associations between exposure markers and outcome markers. Wilcoxon signed-rank test was 
used to explore trends over time for two related samples (e.g. extent of engagement in chimney 
sweeping tasks during two different time periods). Trend analysis using Jonckheere-Terpstra test 
or linear regression models was also performed to examine dose-response relationship between 
exposure markers and outcome markers.  
For Study II and Study IV, principal component analysis was performed to examine clustering 
of study groups according to proteomics data. Principal component regression analysis followed 
by Kolmogorov-Smirnov test (KS test) was considered to explore potential confounders when 
examining the differences in serum protein concentrations between study groups. False discovery 
rate correction (FDR<0.05) was applied to adjust for multiple comparisons. 
4.9 PATHWAY AND GENE ONTOLOGY ANALYSES 
These analyses were employed in Study II and Study IV to explore relevant pathways and 
biological functions for the differentially expressed proteins between chimney sweeps and 
controls. Ingenuity Pathway Analysis (IPA) software (Qiagen, Hilden, Germany) and the online 
tool WebGestalt (www.webgestalt.org) were used to perform the analyses.  
4.10 ETHICAL CONSIDERATIONS 
In our studies, ethical permits were obtained from relevant ethical committees i.e. the Regional 
Ethics Committee at Lund University, Lund, Sweden and the Regional Ethics Committee at 
Uppsala University, Uppsala, Sweden. Written informed consent was obtained from all 
individuals prior to participation. The informed consent encompassed adequate and 
understandable background information (in Swedish language) about study rationales and 
  
28 
 
purposes, type and amount of samples needed, and method of handling confidential personal data 
and ensuring participants’ privacy. Other aspects of the informed consent include access to the 
measurements (blood pressure, weight and height) and information about potential risk of 
discomfort due to sampling, estimated time of sampling, and handling of biological samples. It 
was also indicated that the findings would be presented at the group level not individual level. All 
participants voluntarily agreed to participate in our studies. It was clearly stated in the informed 
consent that participants have the right to withdraw from the study at any time without motivation 
and with no consequences. As authors, we have an ethical and moral responsibility to deliver the 
findings of our research to participants and, therefore, we have communicated our results, via 
written reports and smaller meetings as well as larger conferences, with the chimney sweeps’ 
union (Kommunal) and the chimney sweeps’ employer organization (SSR). Another ethical 
consideration is that all authors in all published or ongoing studies declare that they have no 
conflict of interest.  
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5 RESULTS 
5.1 STUDY I 
5.1.1 Characteristics of study groups 
Chimney sweeps (n=151), compared with controls (n=152), had similar median age (43 y), lower 
BMI, and higher frequency of party smokers, snus users, and small-town residents (P<0.05). The 
two study groups did not differ in other lifestyle factors such as passive smoking, level of 
education, physical activity, and intake of different dietary items; however, more chimney sweeps 
were recruited in autumn compared with controls (P<0.05).  
5.1.2 Characteristics of chimney sweeping profession 
Although it has been decreasing over time, soot sweeping in private homes was the major task 
for chimney sweeps constituting more than 50% of their working time, compared with the other 
tasks (Figure 10). Comparing the periods 1975–2002 and 2002–2013, a decrease in the use of oil 
fuel by clients and an increase in the use of pellets and wood (for fireplaces) were observed 
(P<0.05). In addition, more than 50% of the chimney sweeps did not use mask during soot 
sweeping in private homes (Figure 11). 
 
 
 
 
 
 
 
 
 
 
Figure 10. Trends for fraction of work (%) for different work tasks from 1963 to 2013. *Wilcoxon signed 
rank test for work tasks before/after the year 2002. Standard errors are represented by whiskers on top of each 
bar (adapted from Study I; Alhamdow et al. 2017b).  
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Figure 11. Trends for use of different fuel materials and use of masks reported by chimney sweeps. (a) 
Percentage of use of different types of fuel used by clients whenever chimney sweeps were doing soot sweeping 
for boilers or chimneys of fireplaces during the period (1975 to 2013). The whiskers represent standard errors. 
*P value of Wilcoxon signed rank test for use of fuel by clients before/after the year 2002. (b) Percentage of 
chimney sweeps who used masks during different work tasks (adapted from Study I; Alhamdow et al. 2017b). 
5.1.3 PAH exposure  
Chimney sweeps had higher concentrations of all 4 monohydroxylated metabolites of PAH (1-
OH-PYR, 2-OH-PH, 3-OH-BaP, and 3-OH-BaA) compared with controls (P<0.001; adjusted for 
age, BMI, and smoking) (Table 3). For example, the median value of 1-OH-PYR was 0.39 (µg/g 
creatinine) for nonsmoking chimney sweeps compared with 0.06 (µg/g creatinine) for 
nonsmoking controls (around 7 times difference). The 4 metabolites were intercorrelated 
(P<0.001; average rS>0.79; for nonsmoking chimney sweeps). Further, soot sweeping (in the past 
12 months) was positively associated with the concentrations of all 4 PAH metabolites (P<0.001; 
linear regression models adjusted for age, BMI, and smoking). It is worth mentioning that the use 
of gloves and masks did not correlate with the concentrations of PAH metabolites.   
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5.1.4 PAH exposure and classical markers of CVD risk 
Chimney sweeps had higher serum concentrations of homocysteine, cholesterol, and HDL 
compared with controls (P<0.05; adjusted for age, BMI, and smoking; Table 3). Moreover, the 
PAH metabolites 2-OH-PH, 3-OH-BaP, and 3-OH-BaA were positively associated with diastolic 
blood pressure among chimney sweeps (P<0.05; adjusted for age, BMI, and smoking; Table 4). 
In addition, weak non-significant associations were observed between PAH metabolites and 
homocysteine (positive estimates) and HDL (negative estimates) (P>0.05; Table 4). 
 
Table 3. Differences between chimney sweeps and controls in PAH exposure and traditional 
serum markers of cardiovascular disease (CVD), explored by linear regression analysis adjusted 
for age, BMI, and smoking. 
  
Controls Chimney sweeps 
  
  n Median (min, max) n Median (min, max) P 
Markers of PAH exposure  
1-OH-PYR 
(µg/g creatinine) 
151 0.06 (0.0–0.73) 148 0.39 (0.02–8.8) <0.001 
2-OH-PH 
(µg/g creatinine) 
151 0.14 (0.04–3.1) 148 0.57 (0.08–7.1) <0.001 
3-OH-BaP  
(ng/g creatinine) 
130 1.03 (0.0–17.3) 132 3.35 (0.0–50.1) <0.001 
3-OH-BaA  
(ng/g creatinine) 
144 1.66 (0.04–21.0) 142 4.78 (0.39–43.3) <0.001 
Markers of CVD 
C-reactive protein  
(mg/L) 
148 1.05 (0.42–19.0) 146 0.7 (0.42–46.0) 0.71 
Gamma-glutamyl transferase 
(µkat/L) 
148 0.48 (0.11–2.1) 146 0.49 (0.19–3.2) 0.19 
Homocysteine  
(µmol/L) 
148 13 (4.0–63) 146 16 (5.4–76.0) <0.001 
Cholesterol  
(mmol/L) 
148 5 (2.0–9.7) 146 5.47 (3.2–8.7) 0.003 
High-density lipoprotein 
(mmol/L) 
148 1.15 (0.44–2.6) 146 1.32 (0.7–3.04) 0.004 
Low-density lipoprotein 
(mmol/L) 
148 3.31 (1.2–7.75) 146 3.53 (1.5–6.5) 0.061 
Triglycerides  
(mmol/L) 
148 1.7 (0.41–7.4) 146 1.6 (0.53–8.4) 0.190 
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Table 4. Associations between urinary PAH metabolites and diastolic blood pressure, 
homocysteine, and high-density lipoprotein in chimney sweeps (n=151), explored by linear 
regression analysis adjusted for age, BMI, and smoking. [95% CI = 95% confidence interval]. 
 
Diastolic blood 
pressure (mm Hg) 
Homocysteine  
(µmol/L) 
High-density 
lipoprotein (mmol/L) 
 P B (95% CI) P B (95% CI) P B (95% CI) 
1-OH-PYR 
(µg/L) 
0.067 1.16 (−0.08, 2.40) 0.67 0.27 (−0.98, 1.53) 0.12 −0.05 (−0.10, 0.01) 
2-OH-PH  
(µg/L) 
0.001 1.66 (0.72, 2.60) 0.39 0.38 (−0.49, 1.25) 0.073 −0.04 (−0.08, 0.00) 
3-OH-BaP  
(ng/L) 
0.013 0.31 (0.07, 0.55) 0.26 0.11 (−0.09, 0.32) 0.067 −0.01 (−0.02, 0.00) 
3-OH-BaA 
(ng/L) 
0.044 0.16 (0.01, 0.32) 0.26 0.09 (−0.07, 0.24) 0.042 −0.01 (−0.01, 0.00) 
 
5.2 STUDY II 
5.2.1 Characteristics of study participants  
This study included 116 chimney sweeps and 125 controls. All participants were current 
nonsmokers, for whom serum and urine samples, full questionnaire information and valid 
proteomics data were available. Study groups had similar age and BMI (P>0.05), but differed in 
physical activity, use of snus, and residential area (P<0.05).  
5.2.2 PAH exposure and exploratory CVD-related serum proteins  
We found 25 differentially expressed proteins (DEP) between chimney sweeps and controls 
(P<0.05; adjusted for age, BMI, and FDR). The list of the DEP includes, among others, protein-
glutamine gamma-glutamyltransferase 2 (TGM2), lactoylglutathione lyase (GLO1), NF-kappa-
B essential modulator (NEMO), follistatin (FS), pro-interleukin-16 (IL-16), and heat shock 
protein beta-1 (HSP 27; also called HSPB1). Twenty-four DEP showed higher levels in chimney 
sweeps, compared with controls, and one DEP (i.e. SPON2; spondin-2) showed lower levels 
(Table 5). Three proteins i.e. FS, IL-16, and HSP 27 showed positive associations with PAH 
metabolites in a dose-response manner (P<0.05; adjusted for age, BMI, and day of sampling). 
Pathway analysis showed predicted activation of a number of up-stream regulators, including 
TNF (tumor necrosis factor), that are involved in inflammation. The analysis also showed that 
inflammation and immune response were the top diseases and functions associated with the 
DEP.  
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Table 5. List of the differentially expressed proteins between chimney sweeps and controls 
(FDR<0.05). Data presented are P value, unstandardized beta (B) and 95% confidence interval 
(95% CI) for respective linear regression models.  
                Model 1 
             (unadjusted) 
                Model 2 
(adjusted for age and BMI) 
Protein P B (95% CI) P B (95% CI) 
TGM2 1.5E-24 0.90 (0.75, 1.05) 1.4E-24 0.91 (0.75, 1.06) 
GLO1 6.6E-19 0.59 (0.47, 0.71) 6.0E-19 0.60 (0.47, 0.72) 
FS 8.4E-7 0.37 (0.22, 0.51) 1.1E-7 0.38 (0.25, 0.52) 
NEMO 9.8E-7 0.40 (0.24, 0.56) 2.7E-6 0.38 (0.23, 0.54) 
IL-16 1.4E-5 0.27 (0.15, 0.39) 1.1E-5 0.28 (0.16, 0.40) 
HSP 27 0.0001 0.23 (0.12, 0.35) 6.8E-5 0.24 (0.12, 0.36) 
CXCL1 0.0004 0.23 (0.11, 0.36) 0.0003 0.24 (0.11, 0.36) 
PIgR 0.0004 0.06 (0.03, 0.10) 0.0005 0.06 (0.03, 0.10) 
BOC 0.0007 0.13 (0.06, 0.21) 0.0002 0.13 (0.06, 0.20) 
TIE2 0.0007 0.12 (0.05, 0.18) 0.0008 0.11 (0.05, 0.18) 
STK4 0.0009 0.23 (0.10, 0.37) 0.002 0.21 (0.08, 0.35) 
IL-27 0.001 0.11 (0.05, 0.18) 0.002 0.11 (0.04, 0.17) 
LOX-1 0.001 0.23 (0.09, 0.37) 0.002 0.22 (0.08, 0.36) 
PRSS27 0.003 0.15 (0.05, 0.24) 0.004 0.14 (0.05, 0.24) 
SOD2 0.003 0.09 (0.03, 0.15) 0.002 0.09 (0.03, 0.15) 
IL-17D 0.003 0.09 (0.03, 0.16) 0.004 0.09 (0.03, 0.15) 
ANG-1 0.003 0.10 (0.03, 0.17) 0.004 0.10 (0.03, 0.17) 
MARCO 0.003 0.09 (0.03, 0.15) 0.003 0.09 (0.03, 0.15) 
AGRP 0.005 0.17 (0.05, 0.28) 0.004 0.16 (0.05, 0.27) 
TNFRSF11A 0.009 0.14 (0.04, 0.24) 0.004 0.15 (0.05, 0.25) 
TM 0.011 0.11 (0.03, 0.20) 0.011 0.11 (0.03, 0.20) 
TF 0.013 0.11 (0.02, 0.19) 0.020 0.10 (0.02, 0.19) 
SORT1 0.013 0.08 (0.02, 0.14) 0.008 0.09 (0.02, 0.15) 
SPON2 0.014 -0.05 (-0.09, -0.01) 0.033 -0.04 (-0.08, -0.004) 
MERTK 0.014 0.12 (0.02, 0.21) 0.015 0.11 (0.02, 0.21) 
 
5.3 STUDY III 
5.3.1 Characteristics of study participants 
In addition to the same participants in Study I (151 chimney sweeps and 152 controls), this study 
included creosote-exposed workers (n=19). Median age for creosote-exposed workers was non-
significantly lower (32 y) than chimney sweeps (43 y) and controls (43 y). Use of snus and 
residential area significantly differed between the three study groups (P<0.05). 
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5.3.2 PAH exposure 
As reported in Study I, chimney sweeps had up to 7 times higher concentrations of PAH 
metabolites in urine than controls (P<0.001). Creosote-exposed workers were highly exposed to 
PAH; their concentrations of 1-OH-PYR and 2-OH-PH were 10.7 and 29.6 (μg/g creatinine), 
respectively, compared with 0.06 and 0.14 (μg/g creatinine) for the controls (P<0.001; Table 6). 
However, the concentrations of 3-OH-BaP were non-significantly lower among creosote-exposed 
workers compared with controls (P=0.703), which might be due the European regulation of BaP 
content in the creosote oil manufactured for industrial use (EC 2001).  
Table 6. Concentrations of monohydroxylated PAH metabolites in urine for study groups. 
 
Controlse Chimney sweeps Creosote-exposed workers 
 
n 
Median 
(min-max) 
n 
Median 
(min-max) 
Pe n 
Median 
(min-max) 
Pf 
1-OH-PYRa  151 
0.06 
(0.00–0.73) 
148 
0.39 
(0.02–8.77) 
<0.001 19 
10.7 
(3.2–41.3) 
<0.001 
2-OH-PHb 151 
0.14 
(0.04–3.09) 
148 
0.57 
(0.08–7.10) 
<0.001 19 
29.6 
(12.7–128.5) 
<0.001 
3-OH-BaPc 130 
1.03 
(0.00–17.28) 
132 
3.35 
(0.00–50.15) 
<0.001 19 
0.75 
(0.15–2.45) 
0.703 
3-OH-BaAd 144 
1.66 
(0.04–21.02) 
142 
4.78 
(0.39–43.35) 
<0.001 19 
13.2 
(1.5–32.6) 
<0.001 
a1-hydroxypyrene (μg/g creatinine), b2-hydroxyphenanthrene (μg/g creatinine), c3-hydroxybenzo[a]pyrene 
(ng/g creatinine), d3-hydroxybenz[a]anthracene (ng/g creatinine). eMann-Whitney U test for differences 
between chimney sweeps and controls. fMann-Whitney U test for differences between creosote-exposed 
workers and controls. 
5.3.3 PAH exposure and cancer-related markers  
TL and mtDNAcn were not different between study groups (P>0.05).  Chimney sweeps had lower 
methylation of all CpG sites of F2RL3 and AHRR compared with controls, and significance was 
reached for all three CpG sites of AHRR (P<0.05; Table 7). Creosote-exposed workers had 
significantly lower methylation of F2RL3 (CpG1 and cg03636183) and AHRR (cg05575921) 
compared with controls (P<0.05; Table 7). As well, creosote-exposed workers had significantly 
lower methylation of F2RL3 (cg03636183) and AHRR (cg05575921) compared with chimney 
sweeps (P<0.05).  
No significant associations between PAH metabolites and cancer-related markers were observed 
when evaluated by linear regression analysis among nonsmoking chimney sweeps and controls 
(P>0.05). The linear regression analysis was not performed for nonsmoking creosote-exposed 
workers due to small sample size (n=9).  
 
 
 
  
35 
 
Table 7. DNA methylation of F2RL3 and AHRR for study groups.  
Controls 
n=147 
Chimney sweeps 
n=145-146 
Creosote-exposed 
workers n=19 
CpG site 
Median 
(min-max) 
Median 
(min-max) 
Pa 
Median 
(min-max) 
Pb 
F2RL3 CpG1 89.5 (58.1–100) 88.8 (54.7–98.6) 0.063 87.2 (64.9–96.4) 0.014 
F2RL3 (cg03636183) 76.7 (48.1–86.3) 76.6 (44.8–82.5) 0.786 73.3 (49.5–78.4) 0.003 
F2RL3 average 83.6 (53.8–89.9) 83.0 (50.8–88.2) 0.173 80.1 (57.2–87.1) 0.002 
AHRR CpG1 75.0 (24.7–88.1) 73.0 (20.8–89.7) 0.030 74.1 (30.9–82.8) 0.345 
AHRR CpG2 69.1 (22.7–80.4) 66.5 (20.3–76.6) 0.002 68.7 (30.9–81.7) 0.482 
AHRR (cg05575921) 90 (34.5–100) 88.1 (29.3–100) 0.038 84.9 (37.3–93.6) 0.003 
AHRR average 78.6 (27.3–87.2) 76.2 (23.5–87.5) 0.007 77 (33.7–82.9) 0.262 
aMann-Whitney U test for differences between chimney sweeps and controls. 
bMann-Whitney U test for differences between creosote-exposed workers and controls. 
 
5.4 STUDY IV 
5.4.1 Characteristics of study participants 
This study included current nonsmoking chimney sweeps (n=118) and controls (n=126). 
Proteomics data, questionnaires, and serum and urine samples were available for all participants. 
Chimney sweeps did not differ from controls in age, BMI, and lifestyle factors such as passive 
smoking and intake of different dietary items (P>0.05). However, chimney sweeps differed from 
controls in physical activity, use of snus, and residential area (P<0.05).  
5.4.2 PAH exposure and exploratory cancer-related serum proteins 
We found 17 differentially expressed proteins (DEP) between chimney sweeps and controls 
(adjusted for age, BMI, and FDR; P<0.05; Table 8). All proteins were upregulated in chimney 
sweeps, except syndican-1 (SYND1). Moreover, most of the DEP showed weak positive 
correlations with PAH metabolites, particularly among chimney sweeps (Figure 12) and again, 
SYND1 showed inverse correlations. Kallikrein 13 (KLK13) was the only protein significantly 
associated with more than one PAH metabolite i.e. 3-OH-BaP and 3-OH-BaA (P<0.05; linear 
regression model adjusted for age, BMI, and sample storage time). KLK13 also showed a dose-
response relationship with the aforementioned metabolites among chimney sweeps (P<0.05; 
Jonckheere trend test; Figure 12).  
Pathway analysis including the 17 DEP showed that interferon gamma was an upstream regulator. 
Network analysis and disease and function analysis showed clear involvement of cell adhesion, 
cell movement, cell migration, and cell invasion. Likewise, gene ontology analysis showed cell 
adhesion and migration as the top biological processes.  
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Table 8. Differentially expressed proteins (DEP) between chimney sweeps and controls, explored 
by linear regression models adjusted for false discovery rate. Effect estimate is presented as B 
value. [95% CI= 95% confidence interval].  
                                Model I 
                            (unadjusted) 
Model II  
(adjusted for age and BMI) 
Protein P B (95% CI) P B (95% CI) 
S100A4 <0.001 0.31 (0.22, 0.39) <0.001 0.31 (0.22, 0.39) 
FADD <0.001 0.31 (0.21, 0.40) <0.001 0.30 (0.20, 0.39) 
METAP2 <0.001 0.31 (0.21, 0.42) <0.001 0.33 (0.22, 0.43) 
ANXA1 <0.001 0.52 (0.36, 0.67) <0.001 0.50 (0.35, 0.66) 
S100A11 <0.001 0.22 (0.14, 0.30) <0.001 0.21 (0.13, 0.30) 
VIM <0.001 0.47 (0.28, 0.66) <0.001 0.46 (0.27, 0.64) 
TXLNA <0.001 0.26 (0.12, 0.40) 0.001 0.26 (0.11, 0.40) 
LYN <0.001 0.12 (0.06, 0.18) <0.001 0.12 (0.06, 0.18) 
SCAMP3 0.001 0.21 (0.09, 0.33) 0.001 0.21 (0.09, 0.33) 
SYND1 0.001 -0.17 (-0.28, -0.07) 0.002 -0.17 (-0.27, -0.06) 
KLK13 0.004 0.16 (0.05, 0.27) 0.005 0.16 (0.05, 0.26) 
IGF1R 0.004 0.11 (0.03, 0.18) 0.004 0.11 (0.03, 0.18) 
TCL1A 0.007 0.32 (0.09, 0.55) 0.008 0.31 (0.08, 0.53) 
CXCL13 0.004 0.16 (0.05, 0.28) 0.004 0.17 (0.05, 0.28) 
ITGB5 0.003 0.09 (0.03, 0.16) 0.002 0.09 (0.03, 0.15) 
GPNMB 0.002 0.06 (0.02, 0.10) 0.003 0.06 (0.02, 0.10) 
CEACAM5 0.005 0.26 (0.08, 0.44) 0.007 0.25 (0.07, 0.43) 
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6 GENERAL DISCUSSION  
6.1 CHIMNEY SWEEPING AND PAH EXPOSURE 
We found that chimney sweeps working today are exposed to PAH as their urinary concentrations 
of monohydroxylated metabolites of PAH were up to 7 times higher compared with unexposed 
control workers. Our results indicated that chimney sweeps are exposed to PAH from soot 
sweeping as PAH metabolite concentrations were positively correlated with the amount of time 
spent with soot sweeping; a task that involves removing soot from chimneys. In addition, the use 
of gloves and masks (covering the nose and the mouth) was far from optimal.  
Tobacco smoking is a main source of PAH exposure (CDC 2010; IARC 2004), hence we 
compared PAH metabolite concentrations between study groups stratifying by smoking status. 
The PAH metabolite concentrations were slightly lower in nonsmoking participants, yet, the 
differences between chimney sweeps and controls remained the same (up to 7 times). The four 
PAH metabolites were highly inter-correlated among chimney sweeps (average rS=0.79; for 
nonsmokers), but not among the controls (average rS=0.22). This indicates a common source and 
route of PAH exposure among chimney sweeps. The concentrations of urinary PAH metabolites 
have been measured in chimney sweeps in a limited number of studies. The median concentration 
of 1-OH-PYR in our study was 0.56 µg/L (0.39 µg/g creatinine), which is lower than the 
concentrations measured in chimney sweeps from Germany (median; 1.03 µg/L) (Göen et al. 
1995), from Germany and Poland (median; 0.7 µg/L) (Letzel et al. 1999), and from Italy (mean; 
1.6 µg/L; originally reported as µmol/mol creatinine). PAH exposure is common not only among 
chimney sweeps, but also among workers in various industries. It is important to mention that the 
level of PAH exposure may considerably vary between studies even for the same occupational 
group due to the variability in PAH mixtures and working conditions in different workplaces. For 
example, high concentrations of 1-OH-PYR were observed among workers in production of 
fireproof stones (n=19, median; 11.1 µg/g creatinine), converter infeed (n=29, median; 9.4 µg/g 
creatinine), production of refractories (n=84, median; 8.3 µg/g creatinine), production of graphite 
electrodes (n=92, median; 5.5 µg/g creatinine), creosote impregnation (n=19, median; 10.7 µg/g 
creatinine, Study III), and coke production (n=37, median; 3.8 µg/g creatinine) (Förster et al. 
2008; Gündel et al. 2000; Rossbach et al. 2007). Further, urinary concentrations of 3-OH-BaP, a 
metabolite of the carcinogen BaP, among chimney sweeps in our study (median; 3.35 ng/g 
creatinine) appeared to be lower than those for workers in production of fireproof stones (n=19, 
median; 14 ng/g creatinine) (Gündel et al. 2000), but relatively higher compared with workers in 
converter infeed (n= 25, median; 1.2 ng/g creatinine), creosote impregnation (n=19, median; 0.75 
ng/g creatinine, Study III), coke production (n=79, median; 0.5 ng/g creatinine), production of 
graphite electrodes (n=26, median; 1.3 ng/g creatinine), and production of refractories (n=86, 
median; 1.1 ng/g creatinine) (Förster et al. 2008). Taken together, chimney sweeps seem to be 
less exposed to PAH in comparison with other occupational groups when considering 1-OH-
PYR, but more exposed when considering 3-OH-BaP concentrations. Therefore, evaluation of 
several biomarkers of exposure, e.g. urinary PAH metabolites, is of paramount importance for 
exposure assessment. It is worth mentioning that, in addition to PAH, chimney sweeps can also 
be exposed to particles, degreasing chemicals, asbestos, metals, and combustion gases 
(Andersson 1987; IARC 2010); however, these exposures are beyond the scope of this thesis.  
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6.2 PAH EXPOSURE AND CVD-RELATED MARKERS 
In Study I, we found higher serum concentrations of homocysteine, cholesterol, and HDL in 
chimney sweeps compared with controls. Moreover, diastolic blood pressure showed positive 
associations with PAH metabolites in chimney sweeps. In Study II, we found 25 differentially 
expressed proteins (DEP) between chimney sweeps and controls. Of these proteins, FS, IL-16, 
and HSP 27 showed positive associations with PAH metabolites in a dose-response manner. 
Pathway analysis for the DEP suggested inflammation and immune response as the main 
molecular functions, which are involved in development of CVD (Mann Douglas and 
Kirschenbaum 2011; Tracy 1999; Willerson and Ridker 2004).   
Earlier epidemiological studies have shown associations between chimney sweeping and CVD; 
both increased incidence and increased mortality of cardiovascular events were observed among 
chimney sweeps (Gustavsson et al. 1987; Gustavsson et al. 2013; Hansen 1983; Hansen et al. 
1982; Hogstedt et al. 1982; Jansson et al. 2012). Results from an observational study including 
around one million individuals demonstrated that a difference of 10 mm Hg in diastolic blood 
pressure was associated with about 100% difference in mortality (hazard ratio) related to CVD 
(Lewington et al. 2002). Therefore, the associations between PAH metabolites and diastolic blood 
pressure in our study can be of concern. For example, an increase of 1 µg/L in urinary 2-OH-PH 
concentration was associated with an increase of 1.7 mm Hg in diastolic blood pressure. This is 
also consistent with the findings of a population-based study (n= 4765) where concentrations of 
2-OH-PH were associated with higher odds of hypertension (Ranjbar et al. 2015).   
Homocysteine is an amino acid involved in one-carbon metabolism cycle (Finkelstein 1998). 
Evidence from a vast array of observational studies demonstrated positive associations between 
plasma/serum levels of homocysteine and CVD (Casas et al. 2005; Eikelboom et al. 1999; 
Jacobsen et al. 2005; Khandanpour et al. 2009; Perk et al. 2012; Wang et al. 2005; Veeranna et 
al. 2011); however, randomized controlled trials did not support these findings as homocysteine-
lowering supplementation showed no effect on CVD risk, particularly on myocardial infarction 
(Ebbing et al. 2008; Marti-Carvajal et al. 2017). These disparities might be explained by the 
differences in the follow-up periods (longer in observational studies) and presence of selection 
bias in the randomized controlled trials (Hannibal and Blom 2017; Marti-Carvajal et al. 2017; 
Veeranna et al. 2011). Higher levels of cholesterol or/and LDL and lower HDL levels are 
established risk factors for CVD (Pearson et al. 2002). In addition, researchers showed positive 
associations between urinary PAH metabolites and cholesterol levels in a population-based study 
(n=3640) in China (Ma et al. 2018). Given the aforementioned evidence, the higher 
concentrations of homocysteine and cholesterol in chimney sweeps might indicate higher risk for 
future CVD. Although not significant, the associations between homocysteine and PAH 
metabolites could possibly highlight an interaction between PAH exposure and 
homocysteine/one-carbon metabolism. Cholesterol, in turn, was not associated with PAH 
metabolites, which might suggests a role of other concurrent exposures, such as particles. 
The advent of new technologies has enabled us to screen a large number of putative CVD-related 
proteins in serum, including new proteins that were not studied before in relation to PAH 
exposure. Our analysis showed that many of the DEP were involved in inflammation and 
immunological processes. PAH are capable of inducing oxidative stress (Eom et al. 2013; Kuang 
et al. 2013), which in turn can promote inflammation and development of CVD (Cervantes Gracia 
et al. 2017; Elahi et al. 2009; Elahi and Matata 2006). Given that, it is tempting to say that the 
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dysregulation of some of the DEP may be related to PAH exposure. This speculation is 
corroborated by the fact that many of the DEP, including FS and HSP 27, were shown to be 
implicated in oxidative stress, which can be induced by PAH exposure as mentioned before 
(Caccamo et al. 2012; Jo-Watanabe et al. 2014; Lin et al. 2016; Luedde et al. 2007; Wyttenbach 
et al. 2002).  
6.3 PAH EXPOSURE AND CANCER-RELATED MARKERS  
In Study III, we found lower DNA methylation (hypomethylation) of F2RL3 and AHRR genes 
among workers occupationally exposed to PAH, compared with unexposed controls. Particularly, 
the occupational group with the highest PAH exposure (creosote-exposed workers), had the 
lowest DNA methylation compared with the occupational group with lower exposure (chimney 
sweeps) and the unexposed control group. These findings suggest a dose-response relationship 
between PAH exposure and DNA methylation of F2RL3 and AHRR despite the lack of 
association between PAH metabolites and DNA methylation. In Study IV, we found 17 DEP 
between nonsmoking chimney sweeps and controls. The proteins were weakly correlated with 
PAH metabolite concentrations. In addition, one protein (kallikrein-13; KLK13) showed dose-
response relationships with two metabolites of PAH known to have carcinogenic potential. 
Pathway analysis revealed that the DEP were involved in molecular functions related to cell 
movement, cell adhesion, cell invasion, and cell migration; cellular functions relevant for cancer 
(Bendas and Borsig 2012; Hanahan and Weinberg 2011). 
Hypomethylation of F2RL3 (cg03636183) and AHRR (cg05575921) has been strongly associated 
with cigarette smoking (Joehanes et al. 2016) as well as increased risk of lung cancer and CVD 
(Baglietto et al. 2017; Fasanelli et al. 2015; Zhang et al. 2016b; Zhang et al. 2015). In a 
population-based study including about 5000 participants, every 10% lower methylation of 
cg03636183 was associated with a 40% increase in lung cancer mortality and around 30% 
increase in lung cancer incidence (Zhang et al. 2015). Another study by the same research group 
including around 1500 participants aged 50-75 years found that every 5% lower methylation of 
cg03636183 and cg05575921 was associated with 2.3 and 1.6 times increased mortality of lung 
cancer, respectively (Zhang et al. 2016a). Similarly, a nested case-control study (n=600) showed 
that participants in the first quartile of cg03636183 and cg05575921 methylation had 10.5 and 
15.9 times higher odds of developing lung cancer, respectively, compared with those in the fourth 
quartile (Zhang et al. 2016b). Interestingly, a study including four prospective cohorts suggested 
a mediating role of DNA methylation of F2RL3 and AHRR for the association between smoking 
and lung cancer (Fasanelli et al. 2015). In our study, DNA methylation of F2RL3 and AHRR was 
not associated with PAH metabolites. A likely explanation would be the profound differences in 
biological half-lives between PAH metabolites (4–35 h) and DNA methylation (up to years) 
(Buckley and Lioy 1992; Jongeneelen et al. 1990; Shenker et al. 2013).  
F2RL3 participates in a wide range of biological processes including immune response, 
inflammation, and blood coagulation (Vergnolle et al. 2002). One can speculate that altered 
expression of F2RL3 may give rise to imbalance in biological functions relevant for cancer 
development such as blood coagulation and inflammation (Coussens and Werb 2002; Ferrigno et 
al. 2001). AHRR is an essential regulator of aryl hydrocarbon receptor (AhR) and thus, plays a 
fundamental role in metabolism of xenobiotics such as PAH and dioxins (Hankinson 1995). 
AHRR is also capable of regulating inflammatory process and acting as a tumor suppressor 
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protein (Vogel and Haarmann-Stemmann 2017). Altered expression of AHRR was associated 
with both favorable and unfavorable outcomes in relation to cancer (Vogel and Haarmann-
Stemmann 2017; Zudaire et al. 2008). Increased methylation of AHRR was associated with 
reduced mRNA expression in tumor tissues in humans suggesting that AHRR functions as a tumor 
suppressor gene (Zudaire et al. 2008). In contrast, AHRR-knockout mice showed development of 
skin cancer upon exposure to BaP (Vogel and Haarmann-Stemmann 2017). Taken together, the 
interactions between AHRR and AhR as well as between AHRR/F2RL3 and other molecular 
pathways are not well understood and warrant further research to comprehensively elucidate the 
potential role of AHRR/F2RL3 in PAH-induced carcinogenesis. The question of whether PAH 
exposure causes changes in DNA methylation of F2RL3 and AHRR or whether DNA methylation 
mediates the carcinogenic potential of PAH is beyond the scope of this thesis.  
The majority of the 16 putative cancer-related serum proteins that were significantly upregulated 
in chimney sweeps showed weak positive correlations with PAH metabolites. The weak 
correlations can be due to the drastic differences in biological half-lives between PAH metabolites 
(hours) and proteins (minutes to weeks) (Bachmair et al. 1986; Buckley and Lioy 1992; Doherty 
et al. 2009). KLK13 was upregulated in chimney sweeps and showed positive dose-response 
relationships with the metabolites of PAH that have carcinogenic effect (BaP and BaA). KLK13 
is a member of the human kallikrein family and plays a role in various biological functions 
including degradation of different molecules in the extracellular matrix (Kapadia et al. 2004). 
KLK13 has also been suggested to play a role in cancer development, particularly during the 
metastatic stage (Borgono and Diamandis 2004). Similar to the scenario of AHRR, both increased 
and decreased expressions of KLK13 (mRNA and/or protein) were observed in different cancers. 
Increased KLK13 expression was shown in serum from patients with non-small-cell lung cancer 
compared with healthy individuals (Planque et al. 2008). As well, increased KLK13 expression 
was observed in tumor tissue samples from patients with colon cancer compared with the 
expression in nearby normal tissues (Talieri et al. 2009). On the other hand, decreased KLK13 
expression was found in specimens taken from bladders of cancer patients compared with samples 
of nearby normal tissues (Tokas et al. 2017). In the same study, the reduced expression of KLK13 
was associated with cancer invasiveness. Likewise, reduced expression of KLK13 was observed 
in samples from patients of oral squamous cell carcinomas compared with the normal tissues 
(Ishige et al. 2014). In vivo and in vitro studies showed inconsistent expression profiles of KLK13 
in relation to cancer aggressiveness and cell migration (Chou et al. 2011; Ishige et al. 2014). In 
addition to KLK13, the other DEP such as S100A4 (S100 calcium-binding protein A4), S100A11 
(S100 calcium-binding protein A11), FADD (FAS-associated death domain protein), METAP2 
(Methionine aminopeptidase 2), VIM (Vimentin), ANXA1 (Annexin A1), LYN (Tyrosine-
protein kinase Lyn), TXLNA (Alpha-taxilin), SCAMP3 (Secretory carrier-associated membrane 
protein 3), and SYND1 showed dysregulated expression in association with cancer development 
(Cross et al. 2005; Fei et al. 2017; Mashidori et al. 2011; Moraes et al. 2017; Nguyen et al. 2016; 
Nikolova et al. 2009; Satelli and Li 2011; Tourneur et al. 2005; Tucker et al. 2008; Zhang et al. 
2017a; Zhang et al. 2017b). Taken together, it can be speculated that the dysregulated expression 
of these proteins plays a role in physiological functions related to PAH-induced tumorigenesis 
i.e. cell migration and invasion. Thus, the role of KLK13 and other DEP in cancer development, 
particularly in relation to PAH exposure, requires further investigation.  
 42 
 
6.4 STRENGTHS AND LIMITATIONS 
The main strength of this thesis is the individual data on internal exposure to PAH and the 
individual data on a wide range of classical and newly emerging biomarkers related to CVD and 
cancer in occupational groups distinctly different in their workplace PAH exposure. This contrast 
in PAH exposure has enabled detection of subtle differences in the biomarkers between study 
groups and evaluation of dose-response relationships. In addition, we collected extensive 
information regarding lifestyle factors, disease history, and occupational details, which allowed 
controlling for potential confounders and covariates. Another strength is that chimney sweeps and 
controls were all males, similar in age, cigarette-smoking habit, and relatively similar in BMI. 
On the other hand, some limitations should be commented upon. The design of all studies was 
cross-sectional, which does not permit inference of causality. The difference in company response 
rate between chimney sweeps (87%) and controls (58%) might have introduced a selection bias. 
However, the controls’ health status is an unlikely reason for non-participating control companies. 
Some managers of these companies gave the reason that their employees could not leave their 
daily tasks and dedicate time for participation. Further, information about diet for the day or week 
of sampling was not available. Such data would be relevant for exposure assessment as the 
concentrations of PAH metabolites in urine can be influenced by the consumption of some food 
items such as grilled or smoked meat. Still, we did not observe differences between study groups 
in the intake of different dietary items as assessed by questionnaire. The LC-MS/MS analysis of 
the monohydroxylated metabolites of BaP and BaA encountered some challenges due to their 
low concentrations, compared with the metabolites of pyrene and phenanthrene. This was 
translated into a number of samples being “undetermined” after analysis of 3-OH-BaP and 3-OH-
BaA, while almost all samples were successfully analysed for 1-OH-PYR and 2-OH-PH. It is 
worth mentioning that the 4 PAH metabolites were strongly inter-correlated among chimney 
sweeps. Even though chimney sweeps are mainly exposed to PAH from soot, they may 
concurrently be exposed to particles (that can adsorb PAH on their surface), metals, detergents or 
degreasing agents, and combustion gases. Therefore, there is a possibility that these unmeasured 
exposures could have contributed to the observed effects. Indeed, this is an issue in every human 
epidemiological study as it is impossible to measure all potential exposures. Further, the 
percentage of DNA methylation can vary between different types of leukocytes (Adalsteinsson 
et al. 2012). In our study, we extracted DNA from whole blood samples and we did not have 
information about white blood cell count to adjust for. Yet, adjustment for white blood cell count 
has been shown to be non-influential on DNA methylation of the CpG sites cg03636183 and 
cg05575921 (Tsaprouni et al. 2014).  
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7 CONCLUSIONS  
The key findings of this thesis are (i) chimney sweeps working today are exposed to polycyclic 
aromatic hydrocarbons (PAH) and (ii) chimney sweeps appeared to exhibit early biological 
changes related to development of CVD and cancer. These molecular changes among chimney 
sweeps are summarized as follows: 
 Increased diastolic blood pressure with increased PAH exposure 
 
 Increased serum levels of homocysteine and cholesterol 
 
 Altered serum profile of proteins involved in biological processes relevant for CVD 
development, i.e. inflammatory response and immune function 
 
 DNA hypomethylation (low methylation) of the genes F2RL3 and AHRR; relevant for 
risk of cancer and CVD 
 
 Altered serum profile of proteins involved in biological processes relevant for cancer 
development, i.e. cell movement, cell migration, and cell invasion 
 
We found dose-response relationships between PAH metabolite concentrations in urine 
(representing the PAH exposure) and some of the markers such as diastolic blood pressure and a 
number of serum protiens, which supports the notion that these associations were, at least partly, 
due to PAH exposure. 
 
Our findings support the need for reducing PAH exposure among chimney sweeps and other 
occupational groups, which could be achieved by encouraging the use of protective equipment 
and  introducing better work routines. Our findings also encourage further exploration of early 
markers related to PAH-induced CVD and cancer.   
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8 PUBLIC HEALTH IMPLICATIONS AND FUTURE 
PERSPECTIVES  
Exposure to PAH is a global problem due to the omnipresent nature of these chemicals. In other 
words, not only chimney sweeps or other occupational groups are exposed to PAH, but also the 
general population; predominantly from cigarette smoking, wood burning, diesel exhaust 
emissions, air pollution, etc. Therefore, the findings of this thesis are of high relevance for 
individuals exposed to PAH from workplace as well as for the general public.  
 
This thesis, by studying early markers of diseases, highlights mechanisms for occupational 
diseases and substantially contributes to the field of occupational medicine. 
 
 
This thesis provides novel perspectives for future research, which should focus on: 
 
 Investigating the effect of occupational PAH exposure using a longitudinal design, which can 
be achieved by following up the current group of workers 
 
 Investigating the effect of occupational PAH exposure in a larger sample size including 
additional occupational groups 
 
 Investigating additional markers of disease in association with PAH exposure and other 
potential exposures 
 
 Analysing additional PAH metabolites in urine to obtain a more precise exposure assessment 
 
 Analysing exposure biomarkers that can reflect long-term PAH exposure such as PAH-DNA 
adducts and PAH-protein adducts 
 
 Investigating additional occupational exposures among chimney sweeps to address the 
question concerning the contribution of other unmeasured exposures to the effects observed in 
this thesis relative to PAH exposure 
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9 POPULAR SCIENCE SUMMARY (ENGLISH) 
The journey from healthiness to illness may happen suddenly (e.g. car accident) or take place 
over years developing key changes ultimately leading to disease. In some scenarios, however, the 
long journey might be shortened when risk factor(s) – factors that increase the chance of getting 
the disease, are present; the more the risk factors, the higher the chance of getting the disease. For 
example, smoking and low physical activity are risk factors for cardiovascular diseases (or CVD 
for short), which means that smokers and those who do not exercise are more likely to get CVD 
as compared with nonsmoking and physically active people. However, that does not mean all 
smokers or physically inactive people will get the disease. The risk factor may also be an exposure 
to chemicals from work (getting in contact with chemicals by inhalation, skin contact or 
ingestion). Exposure from work may not only increase the chance of getting the disease, but also 
accelerate disease development. There are also disease-indicators (biomarkers), which can tell us 
whether the disease is approaching or already present. It is like when you enter your home with a 
welcoming smell of cake; an indicator that your mom is preparing a cake or she is already done 
with it.  
Every time you burn wood in the fireplace in your cozy house, a black material so-called soot is 
formed and accumulated on the inner walls of the chimney; the fireplace lung. Soot mainly 
contains a group of chemicals known as polycyclic aromatic hydrocarbons (PAH). To maintain 
the chimney, soot must be removed by skilled workers i.e. chimney sweeps (chimney sweepers). 
However, this work historically comes with a cost on workers’ health. Several studies have shown 
increased occurrence of CVD and cancer among chimney sweeps. Exposure to soot had been the 
main suspect (risk factor) for these health problems. In this thesis, we aimed to study the extent 
of soot exposure as well as explore potential mechanisms or disease-indicators (biomarkers) 
relevant for CVD and cancer in chimney sweeps recruited from southern Sweden. We found (i) 
high levels of PAH exposure (risk factor), (ii) higher levels of disease-indicators of CVD in blood 
(homocysteine and cholesterol), (iii) higher diastolic blood pressure associated with higher PAH 
exposure, and (iv) changes in blood levels of a number of CVD-related proteins mainly involved 
in inflammation; a molecular response highly relevant for CVD. For the sake of simplicity, the 
latter 3 factors (ii, iii, and iv) could be called disease-indicators (biomarkers) for CVD. We also 
found similar disease-indicators for cancer i.e. (i) changes in DNA methylation related to cancer 
and (ii) changes in blood levels of cancer-related proteins primarily involved in cellular functions 
relevant for cancer formation such as cell movement, cell migration, and cell invasion.  
In conclusion, we found that chimney sweeps working today are exposed to PAH (risk factor). 
We also found a number of disease-indicators associated with CVD and cancer. Given the PAH 
exposure among chimney sweeps, our findings suggest that chimney sweeps might be at higher 
risk for CVD and cancer. Therefore, PAH exposure among chimney sweeps as well as other 
occupational groups should be reduced by applying more effective protective measures and 
promoting better work practices. In addition, further research exploring early markers of disease 
in PAH-exposed workers is encouraged.       
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10 POPULAR SCIENCE SUMMARY (SVENSKA) 
Resan från hälsa till sjukdom kan hända plötsligt (t ex genom en bilolycka) eller ske över lång tid 
genom långsamma förändringar som slutligen leder till sjukdom. I vissa scenarier kan dock den 
långa resan bli avsevärt kortare. Det kan ske när riskfaktorer - faktorer som ökar risken att få en 
sjukdom - är närvarande. Ju fler riskfaktorerdesto högre är risken för att få sjukdomen. Till 
exempel är rökning och låg fysisk aktivitet riskfaktorer för hjärtkärlsjukdomar (kardiovaskulär 
sjukdom, förkortat CVD), vilket innebär att rökare och stillasittande personer är mer benägna att 
få CVD jämfört med icke-rökare och fysiskt aktiva personer. Men det betyder inte att alla rökare 
eller fysiskt inaktiva människor kommer att utveckla sjukdomen. En riskfaktor kan också vara 
exponering för kemikalier på arbetsplatsen (via inandning, hudkontakt eller intag via 
magtarmkanalen). Exponering på arbetet kan inte bara öka risken att få sjukdomen, utan också 
påskynda sjukdomsutveckling. Det finns sjukdomsindikatorer (biomarkörer) som kan berätta 
huruvida sjukdomen närmar sig eller redan är närvarande. Det är som när du kommer in i ditt 
hem med en välkomnande doft av kanelbullar; en indikator på att din mamma förbereder eller 
redan gjort en plåt. 
Varje gång du eldar ved i eldstaden i ditt mysiga hus bildas ett svart material, så kallad svartsot, 
som ansamlas på skorstenens inre väggar, eldstadens lungor. Svartsot innehåller huvudsakligen 
en grupp av cancer-relaterade kemikalier som kallas polycykliska aromatiska kolväten (PAH). 
För att upprätthålla skorstenens funktion måste svartsot avlägsnas av kvalificerade yrkespersoner, 
dvs skorstenssvetsare (skorstensfejare). Men detta arbete kommer historiskt med en kostnad för 
arbetarnas hälsa. Flera tidigare studier har visat ökad förekomst av CVD och cancer hos 
skorstensfejare. Exponering för sot har varit den huvudmisstänkta riskfaktorn för dessa 
hälsoproblem. Syftet med denna avhandling har varit att studera omfattningen av sotexponering 
samt utforska potentiella mekanismer eller sjukdomsindikatorer relevanta för utveckling av CVD 
och cancer hos skorstensfejare i Sverige. Hos skorstensfejare fann vi (i) höga halter av PAH 
(analyserat i urin), ii) förhöjda blodnivåer av homocystein och kolesterol, iii) högre diastoliskt 
blodtryck med högre PAH-exponering, och (iv) förändringar i blodhalten av ett antal CVD-
relaterade proteiner som huvudsakligen är involverade i inflammation. De senare 3 fynden (ii, iii 
och iv) kan ses som sjukdomsindikatorer för CVD. Vi hittade också liknande sjukdomsindikatorer 
för cancer, dvs (i) förändringar i DNA-metylering, som kopplats till risk för lung, i samband med 
cancer och (ii) förändringar i blodhalten av proteiner som huvudsakligen är involverade i cellulära 
funktioner som är relevanta för utveckling av cancer, såsom cellrörelse, cellmigration och 
cellinvasion. 
Sammanfattningsvis fann vi att skorstensfejare idag utsätts för PAH i arbetet. Vi hittade också ett 
antal sjukdomsindikatorer förknippade med CVD och cancer. Dessa resultat tyder sammantaget 
på att skorstensfejare kan löpa högre risk för utveckling av CVD och cancer och att denna risk 
kan vara kopplad till PAH-exponering. Därför bör PAH-exponering bland skorstensfejare 
minimeras genom att man tillämpar effektivare skyddsåtgärder och bättre arbetsmetoder.   
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 )اللغة العربية( YRAMMUS ECNEICS RALUPOP 11
أو شاهق  ى الحالة المرضية بشكل مفاجئ كما هو الحال عند السقوط من علوإلقد يحدث التحول من حالة السلامة الصحية 
نسان عبر السنين وذلك لأن تشكل المرض يتطلب يتطور المرض في جسم الإ الأحيانحوادث السيارات. ولكن في أغلب في 
مراض القلبية لى وجود المرض بشكله الصريح كما هو الحال في الأإتظافر عدة مكونات وعوامل تؤدي في نهاية المطاف 
. على سبيل المثال، التدخين وعدم ممارسة  )srotcaf ksir(الوعائية والسرطان. بعض هذه العوامل يسمى "عوامل خطر"
لديهم احتمال أعلى ن المدخنين والذين لا يمارسون الرياضة أصابة بأمراض القلب. هذا يعني خطر للإ املاالرياضة هما ع
وكل من  مدخنمع من هم غير مدخنين ويمارسون الرياضة. يجدر القول هنا بأن ليس كل  مقارنةصابة بأمراض القلب للإ
من . معتبرةدراسات علمية بطة من نمستكبر أنما الكلام هنا عن احتمالية إبالمرض،  حتما   هو غير رياضي سوف يصاب
سامة خلال العمل اليومي سواء كان عن طريق التنفس, الجلد, أو حتى الفم. يمكن لهذا عوامل الخطر أيضا التعرض لمواد 
 ما يمسى واسمات المرض يضا  أهناك التعرض للمواد السامة من العمل أن يزيد ويسرع معدل الإصابة بالمرض بين العمال. 
التي تخبرنا أن المرض قد حدث أو أنه في طريقه للحدوث, كما هو الحال عندما تدخل البيت وتشم  وهي )srekramoib(
 رائحة "المحشي" والتي تعتبر في هذه الحال "واسمة" لطبختك المفضلة. 
كل واحد منا لديه مدفأة "صوبة" في منزله والتي عادة ما تعمل بالديزل "المازوت" أو الخشب. ستلاحظ بعد فترة أن هناك 
مادة سوداء تدعى "السخام أو الشحوار" قد تشكلت من احتراق الديزل أو الخشب أو أي مادة أخرى قابلة للاحتراق. المكون 
ية متعددة الحلقات وهي مركبات سامة وبعضها يؤدي للسرطان. هناك عمال الأساسي للسخام عبارة عن مركبات كربون
مهمتهم الرئيسية هي إزالة السخام من المدافئ والمداخن ولذلك فهم معرضون (على تماس) لهذه المركبات الكربونية طوال 
دة يرجعون من عملهم وقد فترة عملهم عن طريق استنشاق السخام أو ابتلاعه أو عن طريق الامتصاص عبر الجلد, فهم عا
غطى السخام الأجزاء المكشوفة من أجسادهم. سبق للعديد من الدراسات العلمية أن أشارت إلى معدلات مرتفعة للأمراض 
القلبية الوعائية والسرطان بين عمال المداخن. لذلك هدفت هذه الأطروحة إلى معرفة مدى التعرض للمركبات الكربونية بين 
ضا استكشاف الأليات الجزيئية المحتملة والتي قد تؤدي لأمراض القلب والأوعية والسرطان. لتحقيق هذه عمال المداخن وأي
الأهداف قمنا بجمع عينات بول ودم من عمال مداخن وكذلك من عمال في مستودعات تخزين الأغذية (لا يتعرضون للسخام 
ت البول وقياس الواسمات المرضية في عينات الدم. وجدنا بعد من العمل) للمقارنة. قمنا بقياس المركبات الكربونية في عينا
تحليل البيانات أن تركيز المركبات الكربونية كان أكبر بسبع مرات في عينات عمال المداخن مقارنة مع نظرائهم من عمال 
أعلى من  المستودعات مما يشير إلى تعرض واضح لهذه المركبات السامة لدى عمال المداخن. وجدنا أيضا تراكيز
الكوليسترول والحمض الأميني هوموسيستيين في دم عمال المداخن وكذلك أيضا علاقة طردية بين تراكيز المركبات 
جميعها علامات أو واسمات للأمراض القلبية. ليس هذا فحسب بل وجدنا أيضا تغيرات  -الكربونية وضغط الدم الانبساطي
لدى عمال المداخن مرتبطة بزيادة احتمال الإصابة  )noitalyhtem AND(في متللة بعض جينات المادة الوراثية 
بالسرطان. وأخيرا وجدنا اضطرابا في تراكيز مجموعة من البروتينات في الدم لدى عمال المداخن والتي لها علاقة مع 
 تطور الأمراض القلبية الوعائية والسرطان.
لمواد الكربونية وظهرت لديهم علامات قد تشير إلى إمكانية وخلاصة القول هي أننا وجدنا أن عمال المداخن معرضين ل
إصابتهم بالأمراض القلبية الوعائية والسرطان. وهذا يحثنا للقول بضرورة تقليل تعرض عمال المداخن للمركبات الكربونية 
 مركبات السامة. وذلك باستخدام وسائل حماية ووقاية أو باستنباط طرق عمل جديدة تؤدي إلى حماية العمال من هذه ال
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12  POPULAR SCIENCE SUMMARY (DEUTSCH) 
Die Entwicklung von Gesundheit zum Krankheitsfall kann sich schlagartig vollziehen (z.B. 
Autounfall) oder sich über längere Zeit entwickeln, bleibende Veränderungen verursachen, bis 
schlussendlich zur Erkrankung führen. Jedoch kann sich so ein Ablauf in manchen Szenarien 
beschleunigen wenn gefährdende Umstände vorliegen, die die Erkrankungwahrscheinlichkeit 
fördert; je mehr solcher Umstände vorliegen, desto höher liegt diese Wahrscheinlichkeit. 
Raucher und unsportliche Personen unterliegen beispielsweise Risikofaktoren für 
Herzerkrankungen (Herz-Kreislauf-Erkrankungen, kurz HKL), das heißt sie erkranken 
wahrscheinlicher an HKL, als Nichtraucher und sportliche Personen. Das soll allerdings nicht 
bedeuten, dass die betreffenden Personengruppen daran erkranken werden müssen. Ein anderer 
Risikofaktor kann auch vorliegen, wenn man am Arbeitsplatz Chemikalien ausgesetzt ist und 
sie über die Atemwege, der Haut oder der Speiseröhre aufnimmt. Dieser Umstand kann nicht 
nur das Erkrankungsrisiko sondern auch den Krankheitsverlauf beschleunigen. Außerdem gibt 
es Krankheitsindikatoren (Biomarker), die verraten können, ob eine Krankheit sich anbahnt 
oder bereits ausgebrochen ist. 
Jedesmal, wenn Holz in einem Kamin eines behaglichen Hauses brennt, bildet sich eine 
schwarze Substanz, der sogenannte Ruß, welcher sich an den Schornsteininnenwänden 
ansammelt; ”die Lunge“ des Kamins. Ruß enthält polyzyklische aromatische 
Kohlenwasserstoffe (PAK); eine Chemikaliengruppe, die den größten Anteil ausmacht. Zur 
Instandhaltung des Kamins muss der Ruß von einem Facharbeiter entfernt werden, einem 
Schornsteinfeger. Rückblickend in die Berufsgeschichte geht allerdings das Verrichten dieser 
Tätigkeit bis heute auf die Kosten der Gesundheit. Verschiedene Studien belegen ein erhöhtes 
Auftreten von HKL und Krebs unter Schornsteinfegern. Dem Ruß ausgesetzt worden zu sein 
ist dabei Hauptursache dieser Gesundheitsprobleme. Mit dieser Doktorarbeit untersuchten wir, 
bei dafür angeworbenen Schornsteinfegern in Südschweden, gezielt das Ausmaß der 
Rußaussetzung, sowie verdächtige Vorgänge oder Krankheitsindizien im Zusammenhang mit 
HKL und Krebs. Im untersuchten Urin dieser Personen stellten wir (I) hohe PAK-Werte fest, 
(II) höhere Werte von Krankheitsindikatoren zu HKL im Blut (Homocysteine und Cholesterin), 
(III) höherer diastolischer Blutdruck im Zusammenhang mit PAK-Belastung, und (IV) 
Änderungen der Blutwerte diverser HKL-relevanter Proteine, die mit Entzündungen 
beträchtlich zusammenhängen - Eine biologische Reaktion die HKL bedeutend begünstigt. Der 
verständlicheren Einfachheit halber: Die letzteren Faktoren (II, III, IV) dürften als 
Krankheitsindikatoren für HKL angesehen werden. Ähnliche Krankheitsindikatoren fanden wir 
auch für Krebs, d.h. (I) Änderungen an den Grundbausteinen der Erbsubstanz von Zellen 
(DNA-Methylierung), und (II) veränderte Blutwerte von Proteinen, die hauptsächlich an 
Krebsrelevanten Zellfunktionen beteiligt sind wie etwa sämtlichen Zellbewegungen 
(Zellmigration, Zellinvasion, etc). 
Schlussfolgernd beobachteten wir nicht nur, dass Schornsteinfeger PAK ausgesetzt sind, 
sondern eine große Zahl an Krankheitsindikatoren für HKL und Krebs. Unter solcher PAK-
Aussetzung lässt unsere Beobachtung darauf schließen, dass diese Berufsgruppe einem 
größeren Erkrankungsrisiko ausgesetzt ist. Daher sollte diese Gefahr durch effektivere 
Schutzmaßnahmen und bessere Arbeitsmethoden reduziert werden.  
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